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ABSTRACT
The object of this dissertation was to use a computational approach to predict and
understand new psychoactive substances (NPS) to develop a database for state and federal crime.
The primary scope of the dissertation was to better understand the interactions that take place
between new psychoactive substances and their corresponding receptors. Through analysis of the
interactions between the amino acids within the receptors and the NPS, an understanding into the
pharmacology and toxicology of these drugs can be gained. NPS such as synthetic cannabinoids,
fentanyl and its analogs, and kratom have become more problematic for both state and federal
crime labs, as they rush to keep up with new compounds that appear on the drug market for
recreational use. NPS pose many issues within the criminal justice field. A main issue is the
inability of agencies, like the Drug Enforcement Administration (DEA), to keep up with the
increasing number of NPS that are used recreationally and have a high potential for abuse. When
a new compound surfaces, it can take weeks and sometimes months to identify the compound
and understand its properties. This project used the molecular modeling software from
Schrödinger, Maestro, to virtually dock NPS of interest to their receptors. Following thorough
docking studies of known synthetic cannabinoids, possible new structures of synthetic
cannabinoids were designed and studied in the same way. This project focused on the specific
structural characteristics of these compounds and how those characteristics influence the binding
of the ligand to its receptor. Specific residue interactions taking place within the binding pocket
of the receptor were also analyzed. This project sets the foundation of a larger project that will
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lead to a database, that can be made available to all state and federal crime laboratories,
containing potential NPS that will aid in the rapid identification and pharmacological
understanding of previously unidentified compounds.
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ABBREVIATIONS AND SYMBOLS
NPS – New Psychoactive Substances
DEA – Drug Enforcement Administration
UNODC – United Nations Office on Drugs and Crime
Δ9-THC – Δ9 -tetrahydrocannabinol
EMCDDA – European Monitoring Centre for Drugs and Drug Addiction
CB1 – Cannabinoid Receptor 1
CB2 – Cannabinoid Receptor 2
GPCR – G-protein Coupled Receptor
GTP – Guanosine Triphosphate
GDP- Guanosine Diphosphate
CNS- Central Nervous System
PNS – Peripheral Nervous System
G – Gibbs Free Energy
H – Enthalpy
S – Entropy
OPRL1 – opioid receptor like 1
pH – hydrogen ion concentration
pKa – strength of an acid
Ka – acid dissociation constant
NMR – Nuclear Magnetic Resonance
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ppm – parts per million
m/z – mass-to-charge
amu – atomic mass units
3D – Three Dimensional
2D – Two Dimensional
SP – Standard Precision
MM-GBSA – Molecular Mechanics-Generalized Born Surface Area
NIST – National Institute of Standards and Technologies
Å – Angstrom, unit of length
Ki – binding affinity
kcal/mol – kilocalorie per mole
nM – nanomolar
fmol/mL – femtomole / milliliter
ALA – Alanine
ARG – Arginine
ASN – Asparagine
ASP – Aspartic acid
CYS – Cysteine
GLN – Glutamine
GLU – Glutamic acid
GLY – Glycine
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HIS – Histidine
ILE – Isoleucine
LEU – Leucine
LYS – Lysine
MET – Methionine
PHE – Phenylalanine
PRO – Proline
SER- Serine
THR – Threonine
TRP – Tryptophan
TYR – Tyrosine
VAL – Valine
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CHAPTER 1
INTRODUCTION

1.1 New Psychoactive Substances (NPS)
The objective of this dissertation is to gain a better understanding of the pharmacology
and toxicology of specific drugs of abuse through the use of molecular modeling and docking
studies. This project will focus on new psychoactive substances (NPS) including synthetic
cannabinoids, fentanyl and its analogs, and the plant based NPS known as kratom. NPS emerged
on the drug scene in the recent years and have been labeled as “legal highs”. However, there is
very little information on what influences the adverse effects associated with these substances.1
There is also a large misconception that since some of these drugs are sold legally and that they
are safer than the drug they were designed to mimic. 2 In reality the drugs sold are not regulated
and they can vary from one package to the another because of the large quantity of analogs.2
The growth of NPS are still increasing as more and more drugs are developed to stay ahead of
the law. Across the United States there is a reported 301-423 substances that are considered NPS
(Figure 1). There are many groups of drugs classified as NPS, including sedatives, opioids,
hallucinogens, stimulants and synthetic cannabinoids (Figure 2). One of the main issues with
NPS in the criminal justice field is the inability to predict new structures related to known NPS,
or analogs, before they appear on the street for recreational use.

1

Figure 1. The global emergence of NPS as of December 2018. Courtesy of the UNODC Early
Warning Advisory, 2019. 1

Figure 2. NPS divided by psychoactive effect group as of December 2018. Courtesy of the
UNODC Early Warning Advisory, 2019. 1
2

Through the studies in chapters 2-6, the specific interactions that take place between NPS
and their corresponding receptors were thoroughly analyzed to better understand the binding
differences that may contribute to adverse effects. Identifying the specific structural
characteristics associated with the essential interactions within the binding pocket were used to
help design potential new compounds which could be intended for recreational use. Once new
compounds have been designed, their toxicological and pharmacological properties can be
studied, and mass spectral data can be calculated with the overall goal of developing a database.
State and federal labs can access the database to rapidly identify and characterize new
compounds.
1.2 Synthetic Cannabinoids
Synthetic cannabinoids came onto the drug scene as an alternative to marijuana.
Synthetic Cannabinoids first made their major appearance in the 1990’s with Dr. John W.
Huffman’s creation of a large number of compounds that were considered to be structural
derivatives of Δ9-tetrahydrocannabinol (Δ9-THC).3 Many other classes of synthetic cannabinoids
soon followed, such as HU and CP which were synthesized by Dr. Mechoulam and the Pfizer
Corporation respectively.3 Initially, the products were widely available, easily attainable, and
legal. Brand names such as ‘Spice’ and ‘K2’ sold herbal packets advertised as incense packs to
be used in aromatherapy. In 2009, Europol’s European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) discovered, like marijuana, many of these packets were being used as
hallucinogenic inhalants.3
Synthetic cannabinoids have been determined to act similarly to Δ9- THC in marijuana
and produce psychoactive effects. Δ9-THC is known to interact with the cannabinoid receptors
CB1 and CB2. These receptors are a part of the endocannabinoid system. Cannabinoid receptor 1
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(CB1) is located in the central and peripheral nervous systems and is responsible for the
psychoactive effects brought on by Δ9-THC.4 Even though there are similarities between Δ9THC and synthetic cannabinoids, many synthetic cannabinoids have been determined to be full
agonists for the CB1 receptor whereas Δ9-THC is only a partial agonist.4 Agonists are able to
bind to the receptor and produce the maximum biological response. Partial agonists bind to the
receptor’s active site as well, but the maximum biological response of the receptor is not
produced. Little is known about these compounds and their effects on humans. More
information is needed on how these compounds interact with the cannabinoid receptors and their
resulting effects.
1.2.1 Endocannabinoid System
The human body naturally produces endocannabinoids that are similar to cannabis
structures.5 These naturally occurring endocannabinoids are a part of what is known as the
endocannabinoid system. The endocannabinoid system includes both the cannabinoid 1 (CB1)
and cannabinoid (CB2) receptors. Originally it was believed that the cannabinoid receptors only
existed in the brain and nerves, but they were later found in other parts of the body including the
skin, heart, and the immune system. The endocannabinoid system plays a role in various
processes throughout the body including appetite control, metabolism, the immune system, etc.5
Both the CB1 and the CB2 receptors are known as G-protein coupled receptors (GPCRs).
GPCRs are membrane bound receptors, located in the membrane of the cell. It is estimated that
one-third to one-half of all drugs commercially available bind to a type of GPCR. 6 All GPCRs
consist of seven segments that are formed from the folding of the receptor. The receptor has
extracellular loops outside of the cell membrane, intercellular loops inside the cell and then
transmembrane portions that exist inside the cell membrane itself.6 These receptors are known as

4

“G-protein coupled” because of their interaction with the G protein within the membrane. G
proteins are responsible for binding guanosine triphosphate (GTP) and guanosine diphosphate
(GDP). When the receptor is activated, and a conformational change occurs, the G protein that is
bound to it also activates. The G proteins bound to GPCRs are heterotrimeric, with alpha, beta,
and gamma subunits.7 The activation of the G protein allows these subunits to send messages
into the cell through the process of signal transduction (Figure 3). 6

Figure 3. Process of GPCR activation by an agonist. This image has been reproduced with
permission of the Springer Nature under copyright license number 4632820585277.6

The synthetic cannabinoids analyzed in this study were all agonists for the CB1 receptor
located in the endocannabinoid system. The CB1 receptor is a GPCR that contains 472 amino
acids and is encoded by the CNR1 gene.8 The CB1 receptor is found predominately in the brain
and throughout the central nervous system (CNS). However, it has also been noted in the
peripheral nervous system (PNS).8 The CB1 receptor is speculated to play a role in many
physiological processes including appetite, memory, depression, anxiety, addiction, and more.
5

Because of its location in the PNS it can also play a role in pain, metabolism, inflammation,
energy and many other physiological and pathological processes.8

1.2.2 General Structural Characteristics of Proteins
Proteins are essential to most biological processes and their function is dictated by their
structure. Proteins are made up of amino acids which each consist of an amino group, a carboxyl
group, a side chain and a hydrogen. The sequence of amino acids in a protein is responsible for
its properties such as the fold of the protein or its surface properties. The amino acids in a protein
are linked through peptide, or amide, bonds. Peptide bonds are covalent bonds that occur
between the carbonyl carbon of one amino acid and the nitrogen of the adjacent amino acid.
Proteins have various structures or conformations.9 The primary structure is the sequence of
amino acids. The secondary structures include two different types of formations, the alpha-helix
and the beta-sheet. In the alpha-helix structure of proteins the backbone of the structure forms
hydrogen between the carbonyl oxygens and the NH hydrogens as turns are made in the structure
and the side chains are pointed outwards. Beta-sheet secondary structures occur when the CO
group and NH group of an amino acids can form hydrogen bonds to adjacent strands of either
sides.9 The next level of structure of a protein is the tertiary structure, which refers to the overall
three-dimensional conformation or fold of the molecule. The conformation of most importance is
that which occurs when the protein is biologically active. The final level of structure is the
quaternary structure, in which multiple chains of proteins are bound together to form one unit.9
(Figure 4)

6

Figure 4. Structure types of proteins. Courtesy: National Human Genome Research Insitiute10

1.3 Fentanyl and Kratom
The second set of NPS analyzed in this study was the synthetic opioids, specifically
fentanyl and its analogs. Fentanyl was first discovered in 1960 but reports of overdoses were not
reported until around 1972 as various methods of administration were becoming readily
available.11 Fentanyl has been found to be 80-100 times stronger, or more potent, than morphine
and 25-40 times more potent than heroin. Fentanyl analogs in the illegal drug market were not
7

reported until around the 1980s.12 One of the most potent analogs is carfentanyl. Carfentanyl has
been found to be up to 100 times more potent than fentanyl. From 1999 to 2011, the number of
fatal opioid analgesic overdoses quadrupled and, for the year 2015, the death toll in the United
States totaled 33,091.13 One reason for this spike in overdose deaths is the now common practice
by drug dealers of lacing heroin with fentanyl in order to increase the high of the abuser and keep
them coming back for more. Fentanyl and its analogs act on the opioid receptor system with the
most prominent receptor being the mu-opioid receptor. The mu-opioid receptor and fentanyl and
its analogs were the focus of this study.
The last set of NPS analyzed in this study belongs to the plant-based NPS group. Kratom,
or Mitragyna speciosa, is a plant found in countries of Southeast Asia. The alkaloids found
within the leaf of the plant are what is currently marketed and sold as the drug kratom. Up to 44
alkaloid compounds have been isolated from the leaves of the Mitragyna speciosa plant. Two of
the alkaloids, mitragynine and 7-hydroxymitragynine, are known to be some of the most
potent.14 These two alkaloids have the potential to be even more potent than morphine. These
alkaloids have been found to act upon the mu-, kappa-, and delta-opioid receptors.15 The work in
this dissertation will focus on the kratom alkaloids and their binding to the mu-opioid receptor.
The popularity of the drug has significantly increased because of its euphoric effects and its
potential to help with opioid withdrawal.16 The increase in popularity in this drug can also be
related to the ease at which one is able to obtain it, as it is legal and sold largely online and even
in some convenience stores. Due to this increase and the addictive effects of kratom, the DEA
has noted kratom as a “drug of concern”. Some cities, however, are taking action and banning
kratom from being sold within the city limits as reports of kratom use and overdoses associated
with kratom are increasing.
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1.3.1 Mu-opioid receptor
Like the cannabinoid receptors, the opioid receptors are also a part of the GPCR family.
There are four types of opioid receptors: mu, kappa, delta and opioid receptor like 1 (OPRL1).
This study focuses on the binding of NPS to the mu-opioid receptor. The opioid system plays a
key role in pain behavior and antinociception. Opioid receptors are found throughout the CNS
and the nociceptive neural circuitry.17 The mu-opioid receptor was first identified in 1973 and
most opioids used for pain interact with the mu-opioid receptor. However, opioids that act on
this receptor have also been known to be mood enhancers and cause euphoria. Similarly to the
CB1 receptor, the mu-opioid receptor binds to a G protein. When the receptor is activated by an
agonist, the G protein subunits are released and are able to act on various signal transduction
pathways.17

1.4 Molecular Docking
Molecular docking is used in the research to virtually dock known and novel NPS to their
receptors. The steps include ligand selection, ligand design, ligand preparation, protein
preparation, receptor grid generation, ligand docking, and binding energy estimations.
The ligand preparation involved generating possible states at a target pH of 7.0 + 2.0
using Epik, which predicts pKa values and determines chemically sensible structures. 18
1.4.1 pH
The pH expresses the acidity of a solution based on its hydrogen-ion concentration. It is
determined by finding the negative logarithm of the hydrogen-ion concentration.19 The pH scale
ranges from 0-14, with 7 being neutral and anything lower than that is considered acidic and
anything higher is basic.
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1.4.2 pKa
A pKa value determines the strength of an acid based on the acid dissociation constant
(Ka). The acid dissociation constant is the ability of compound to donate a proton to a base. The
pKa is found by taking the negative logarithm of the Ka. A lower pKa values indicates a stronger
acid.20
After docking was completed binding free estimations were done for the best possible
poses.
1.4.3 Binding Free Energy
Gibbs free energy (G) is defined as the energy required to be used for work. The energy
is determined using the enthalpy, temperature and entropy. Enthalpy (H) is defined as the
measure of energy in a system that is equal to the heat of the system. Entropy (S) is the measure
of energy that is not available which measures the disorder of a system.21 The free energy of a
reaction can be determined by taking the sum of the free energy of the products minus the sum of
the free energy of the reactants. The binding free energy in this research was estimated using the
following equation: ΔGbind = E_complex (minimized) – (E_ligand (minimized) – E_receptor
(minimized)).22 The binding free energy estimations done in the Maestro software are not
expected to be the same as the experimental binding affinities (Ki), but should be similar in rank
compared to the experimental values. Binding affinity is defined as the strength of interaction
between the ligand and the receptor.23
After the ligands have been docked and calculations have been performed, through the
2D ligand interactions diagram it is possible to analyze the residues interacting with the ligand at
a specific distance. The type of interactions observed are hydrophobic, polar, π-π stacking, πcation, hydrogen bonds and salt bridges.
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1.4.4 Hydrophobic Residues
Hydrophobic residues are amino acids that have a side chain made up of mostly carbons
and hydrogens. The side chains of these residues are nonpolar and therefore do not interact with
water molecules. Nonpolar bonds are formed when electrons between atoms are equally shared.24
1.4.5 Polar Residues
Polar amino acid residues are found to have an -OH or -NH2 group and, due to the
electronegative atoms on their side chains, they are able to form hydrogen bonds.25 A polar
molecule occurs when the electrons between atoms are unequally distributed causing a dipole
moment due to one end of the molecule being slightly positive and the other slightly negative.26
1.4.6 Aromatic (π-π) stacking
π-π stacking is a type of attractive force that can occur between two neighboring aromatic
rings.27 Aromatic rings contain a benzene ring, a ring of six carbons with alternating double and
single bonds, or another similar ring structure. π-π stacking occurs due to the positive
electrostatic potential of one ring interacting with the negative electrostatic potential of another
ring.28
1.4.7 π-Cation Interactions
π-cation interactions are caused by an electrostatic interaction between a cation and the
negatively charged face of an aromatic ring.29
1.4.8 Hydrogen Bonding
Hydrogen bonding is the attraction of hydrogen bond to an electronegative atom, like
nitrogen, oxygen or fluorine, and another electronegative atom. This attraction occurs due to the
dipole-dipole interactions. Dipole-dipole interactions take place when the positive end of a polar
molecule is attracted to the negative end of another.30
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1.4.9 Salt Bridges
A salt bridge is a type of non-covalent interaction that occurs between two ionized sites.
This type of interaction consists of both a hydrogen bond and an electrostatic interaction. Salt
bridges are the strongest type of non-covalent interaction.31

1.5 Spectral Simulation
Following the analysis of the known and designed novel NPS, spectral data was
calculated. The type of potential spectra calculated in this research were 1H NMR, 13C NMR and
mass parent peaks displaying isotopic distribution.
1.5.1 Nuclear Magnetic Resonance (NMR) Spectroscopy
NMR spectroscopy is a nondestructive analytical technique predominately used for
determining the structure of an organic compound. Spectroscopy refers to the study of light and
matter interacting. The theory behind NMR is based on the idea that atomic nuclei are positively
charged, spin on an axis, and create a magnetic field. 32 The orientation of these magnetic fields is
random. When an external magnetic field is applied they can either align with the direction of the
external magnetic field or against it. The applied radiation is absorbed by the nuclei which is
what causes the spins to flip and become in resonance with the external magnetic field. Nuclei
will absorb the radiation at difference wavelengths. The signals detected and used to produce the
NMR spectra are determined by the chemical shifts and the splitting of the signals. The position
of the signal on the spectra is determined by the chemical shift, while the pattern is dependent on
the splitting.32 The chemical shift is the measurement of the change on the spin of the nucleus
caused by the external magnetic field.33 There are two types of NMR utilized in this research, 1H
NMR and 13C NMR. In 1H NMR spin-spin coupling, or splitting, occurs when protons on
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neighboring carbons interact and cause the resonances to split into more than one peak. The
splitting is shown on the spectra as multiple peaks including doublets, triplets and quartets or
singlets if they have not been split. For example, a doublet is caused by one proton on an
adjacent carbon splitting the proton into two, a triplet is caused by two protons on an adjacent
carbon spitting the proton into three peaks and so on. 32 13C NMR is not as sensitive as 1H NMR,
but 13C NMR spectra can display the carbon framework of the compound. 13C NMR deals with
13C

isotope which has a low natural abundance and since it is unlikely that two 13C will be next

to each other spin-spin coupling is not seen. But 1H-13C coupling can be observed between 13C
and the hydrogens they are bound to. However, this method is not typically used, and a technique
called broadband decoupling is used instead. This technique turns off the 1H-13C coupling and
therefore all signals are seen as singlets.34 ChemDoodle was used to determine a 1H NMR and
13C

NMR spectra of the simple compound ethanol and display what can be determined from

NMR spectra. (Figure 5-6)
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Figure 5. 1H NMR spectra of ethanol generated by ChemDoodle. The methane, -CH3 (red),
group signal is displayed at around 1-1.5 ppm and will be a triplet because of the spin-spin
coupling that occurs with the CH2 group (blue). The singlet (green) at 2.8-3.0 ppm is caused by
the H of the -OH. It is a singlet because no coupling occurs. At around 3.5 ppm, the CH 2 group
gives a signal. This quartet occurs form the spin-spin coupling with the three hydrogens on the
neighboring CH3 group.
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Figure 6. 13C NMR of ethanol generated by ChemDoodle. Because only two carbons are present
in this compound, only two singlets are observed. The carbon of the CH 3 (red) signal is observed
around the 15-20 ppm range, while the carbon of the CH2 (blue) signal is observed around the 55
ppm range.

The software used in this research to calculate spectral data was ChemDoddle. The
ChemDoodle software uses an algorithm to identify the key functional groups in the structure
and estimate the chemical shifts. A separate algorithm is then used to examine the chemical
environment around each nucleus. The algorithm is a breadth-first algorithm that is able to
analyze one nuclei by exploring the neighboring nuclei. The splitting is determined through the J
constants and the spins of adjacent nuclei. The J constant is a measure of the interaction between
a pair of protons.35
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1.5.2 Mass Spectrometry
Mass spectrometry is used for a variety of applications including forensic science,
environmental sciences, chemistry, biology, toxicology, proteomics and much more. This
analytical technique measures the mass-to-charge ratio of ionized analytes in the gas-phase,
based on how the ions respond to electric and/or magnetic fields applied to the ions. Mass-tocharge (m/z) is a based off of the mass, or atomic mass units (amu), and z which is a multiplier
of the unit of charge. Mass-to-charge is a unitless measurement. The information gathered for
mass spectrometers is useful in identifying unknown samples, quantitation and examining
various chemical and physical properties of a molecule.36
There are a variety of mass spectrometers, but every mass spectrometer contains the same
three components: an ionization source, a mass analyzer, and a detector (Figure 7).37 Ionization
sources are used to convert the analyte of interest into ions in the gas phase. This step allows for
the fragmentation of some of the analyte to occur. A mass analyzer is then used to separate the
ions by their mass-to-charge. The ion detector is then used to detect and measure the separated
ions.37
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Figure 7. Basic components of a mass spectrometer.
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There are many different types of mass spectrometry instruments. The type and amount
of information obtained from the spectra will vary based on the type of mass spectrometer
instrument used and even what other type of instrument it is coupled with for analysis. In this
research the software ChemDoodle was used just to predict the mass parent peak. The mass
parent peak is the peak that corresponds to the molecular weight of the compound being
analyzed. The parent molecule becomes an ion through the ionization source which causes the
loss of an electron of the molecule and formation of a position ion, the molecular ion. 37 The
molecular ion peak will most likely not be the most intense peak, but it should be the heaviest.
The lower m/z peaks are from the fragmentation of the molecular ion, so it is not possible for
them to have a higher m/z than the parent peak. The spectra produced by ChemDoodle also
displays the isotopic distribution. Most elements have more than one isotope. An isotope is a
form of the element that has a different number of neutrons and therefore a different mass.
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CHAPTER 2
THE COMPUTATIONAL STUDY OF KNOWN AND NOVEL SYNTHETIC
CANNABINOIDS FROM THE JWH FAMILY
2.1 Introduction
Synthetic cannabinoids are man-made chemicals that are meant to mimic the effects of
marijuana, specifically Δ9-THC, the main psychoactive ingredient in marijuana. Although these
drugs have been seen as an “alternative to marijuana” the health effects of the substances are
known to be very severe. Symptoms associated with the use of synthetic cannabinoids include
altered perception, psychosis, anxiety, paranoia, hallucinations, rapid heart rate, violent behavior,
and seizures. Due to the high number of synthetic cannabinoids available the symptoms are
unpredictable and can even be fatal.38
Synthetic cannabinoids are divided into families based on the structure and who designed
the compound. The families include JWH-XXX, CP-XX,XXX, AM-XXX, HU-XXX, WINXXX and more. The JWH-XXX family of synthetic cannabinoids included over 400 structures
of cannabinoids designed by John W. Huffman and his research group at Clemson University.
Huffman’s compound JWH-018 was one of the first synthetic cannabinoids marketed and sold as
“Spice”. The JWH compound started an evolution of new designer drugs appearing in the market
because of how easy and cheap they were to make and how simple it was to design new
structures just by making a simple structural change to the compound. 39
One of the most prominent structural classes within the JWH-XXX family of synthetic
cannabinoids is known as the “naphthoylindoles”. This class of JWH-XXX synthetic
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cannabinoids consist of a common base structure of a naphthalene group linked to an indole
group. These groups are linked by a carbonyl group, like JWH-018. Very similar in base
structure are the “naphthylmethylindoles”. This class also consists of a naphthalene and indole
group but is linked by a methyl group instead of a carbonyl, like JWH-175. Being some of the
first synthetic cannabinoids, JWH-XXX compounds have been studied extensively, especially by
Huffman and his research lab. In 2003, Huffman et al. studied the importance of aromatic
stacking in the “indole” classes of their synthetic cannabinoids.40 This study indicated that, even
though previous research had shown hydrogen bonding as an essential interaction between these
synthetic cannabinoids and the CB1 receptor, they had new evidence showing that this class of
synthetic cannabinoids interact mainly through aromatic, or π-π stacking.
The objective of this study was to investigate the binding properties of known synthetic
cannabinoids in the naphthoylindoles structural class to an active-state CB1 receptor model
through molecular docking. This study thoroughly examined the correlation between aromatic
stacking and the binding of the synthetic cannabinoid ligands. To better understand the influence
of the various structural characteristics of the synthetic cannabinoids, potential new structures
were designed and examined using the same methods. Once the newly designed structures were
analyzed, spectral data was calculated for each structure to begin the development of a database
of known and novel NPS.

2.2 Materials and Methods
Schrödinger’s molecular modeling software, Maestro, was used to examine the binding
of a set of JWH-XXX synthetic cannabinoids to an active-state CB1 receptor model. This study
focused on the naphthoylindole class of JWH-XXX synthetic cannabinoids. The three-
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dimensional (3D) homology model used in this study was designed and validated by the
Doerksen lab at The University of Mississippi, Department of Biomedical Sciences. Since the
development of this model a crystal structure has been published. The crystal structure was
published by Hua et al. in 2017.41 The Doerksen lab has examined the crystal structure and
compared it to the homology model and found only slight differences in the two structures. The
main difference to note is the LYS192 residue. In the crystal structure the side chain is outside
the binding pocket, while in the Doerksen model the side chain is pointing towards the binding
pocket. It was decided that the study would continue with use of the 3D homology model of the
active-state CB1 receptor developed by the Doerksen lab since both structures are comparable.
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Figure 8. Validated 3D homology model of the active-state CB1 receptor developed by the
Doerksen Lab (P Pandey, K K Roy, R J Doerksen, unpublished).

2.2.1 Ligand Selection and Design
The ligands selected for this study were from the naphthoylindole and
naphthylmethylindole classes of synthetic cannabinoids. Naphthoylindole synthetic cannabinoids
consist of a naphthalene group linked to an indole group. In some naphthoylindoles the groups
are linked by a carbonyl group. Naphthoylindoles also can contain an N-linked alkyl chain on
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the indole group. Naphthylmethylindoles have the same base structure but are linked by a methyl
group instead of a carbonyl group.
For this study the known synthetic cannabinoids from the naphthoylindole class used
were JWH-175, JWH-073, JWH-018, JWH-122, JWH-210, and JWH-182. Using these known
compounds, new structures were designed based on structural similarities and examined using
the same methods (Figure 9).

Figure 9. Diagram showing the design of the novel synthetic cannabinoids based on structural
similarities between the parent compounds JWH-175, JWH-073, JWH-018, JWH-122, JWH210, and JWH-182.
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2.2.2 Ligand Preparation
The LigPrep protocol was used to successfully convert ligands into three-dimensional
structures. The preparation of the ligands involves generating possible states at a target pH of 7.0
+/– 2.0 using Epik. Epik is used predict pKa values and determine all chemically sensible
structures.18,42
2.2.3 Receptor Grid Generation
The Receptor Grid Generation application is used to accurately place a grid around the
desired binding pocket of the receptor. This was accomplished by selecting the Δ9-THC ligand
already in the binding pocket. The grid is generated without constraints, rotatable groups and
excluded volumes applied to the receptor. The grid created was used to accurately dock the
ligands into the binding pocket of interest in the CB1 receptor model.
2.2.4 Ligand Docking
After the grid was generated and the desired ligands were prepared, the next step was
Glide Ligand Docking. This step allowed for the prepared ligands to be docked into the receptor
binding pocket selected during grid generation. Docking was completed using the standard
precision (SP) method and force field OPLS3. Flexible ligand sampling was selected and Epik
state penalties were added to the docking score. No constraints were selected to use in docking.
The Gide program is able to produce potential ligand conformations. The program uses a set of
ranked filters to find possible locations on the ligand in the binding pocket of the receptor. The
filters include; 1) side-point search, 2a) diameter test, 2b) subset test, 2c) greedy score, 2d)
refinement, 3) grid minimization, and 4) final scoring.43 The Glide Ligand Docking process is
described by Friesner et al. (2004).43 For each ligand, up to five possible poses were generated
and post-docking minimization was performed. The pose refers to the position and orientation of
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the ligand in relation to the receptor.43 To determine the most accurate pose for each ligand, the
docking scores and Glide Emodel scores were analyzed. Docking scores are an estimation of the
binding free energy and are used to rank poses of different ligands.43,44 The Glide Emodel was
used to compare poses and determine the best, or most likely, pose for each ligand. Docking
scores and Glide Emodel scores are negative. A more negative score means better docking. The
docking of each ligand, when using the same procedure, produces the same values. The
algorithm used by Glide does not require docking multiple times and will produce the same
values each time as long as the same procedure is used. The use of three decimal places is
because differences in some of the values between ligands might not have been seen until the
second or third decimal place. The software allows for more decimal places to be used, but it was
decided to use three decimal places due to some of the small changes observed in the data.

2.2.5 Spectral Simulation
Following the analysis of the known and novel synthetic cannabinoids, spectral data were
calculated for each of the novel structures using spectral simulation software. The software
ChemDoodle was able to produce 1H NMR and 13C NMR spectra as well as a mass parent peak.
The known synthetic cannabinoids were also analyzed in this way and compared to data from the
NIST library to confirm accuracy.
2.3 Results and Discussion
In this study the length of the alkyl chain both on the naphthalene group, as well as on the
indole group, were analyzed. The ligands in this study were examined in two phases, each phase
consisting of two groups of ligands. This was done to better understand the influence certain
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structural characteristics have on the binding of the ligand to the CB1 receptor and what specific
residues interactions are taking place.
2.3.1 JWH-073 and MGCS-175-073
The first groups examined started with JWH-073 and a potential new structure of MGCS175-073. Both of these parent structures contain an N-linked butyl chain and an alkyl chain is
added in increasing length to the naphthalene portion of the structure. In this study the alkyl
chain was increased all the way to a five-carbon, pentyl, alkyl chain. The difference between
these two parent structures is the presence of the carbonyl group on the JWH-073 group.
As the alkyl chain increased on the naphthalene, a trend was seen in both groups of
synthetic cannabinoids in terms of the docking scores (Figure 10). When there was no alkyl
chain present on the naphthalene the docking scores of each group were around the same with
the MGCS-175-073 group being slightly more positive than the JWH-073 group of ligands. The
ligands of the MGCS-175-073 group consistently had more positive docking scores than the
JWH-073 group, with the exception of the MGCS-175-073-5 ligand that had a docking score a
little more negative than the JWH-073-5 ligand. The trend in docking scores was consistent
through the lengthening of the alkyl chain on the naphthalene of each group of ligands. As a
methyl was added to the naphthalene the docking scores became more positive and then
decreased, became more negative, as that methyl was increased to an ethyl group. The docking
scores become more negative again as the ethyl was extended to a propyl. The addition of a
propyl group gave the best, or most negative, docking score for each parent ligand. The docking
scores saw a significant increase, to a more positive docking score, with the addition of a butyl
chain on the naphthalene. The addition of a butyl chain saw the most positive docking scores in
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each group of ligands. The docking scores became more negative as the butyl was lengthened to

Docking Scores (kcal/mol)

a pentyl chain.
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Length of Alkyl Chain on Naphthalene
Figure 10. Docking scores vs length of alkyl chain graph for the JWH-073 and MGCS-175-073
groups.

To get a better understanding of how the structural characteristics of the ligands influence
the binding to the receptor, the specific residue interactions were examined (Figure 11-12).
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Residue Interactions
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Figure 11. Interacting residues observed within 5 Å for the MGCS-175-073 ligand group.
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Figure 12. Interacting residues observed within 5 Å for the JWH-073 ligand group.

The MGCS-175-073 group of ligands contains a N-linked butyl chain and no carbonyl
group was present. For this group of ligands, the number of π-π stacking interactions ranged
from 3-6. The number π-π stacking interactions for the first three ligands, MGCS-175-073,
MGCS-175-073-1 and MGCS-175-073-2 were 4, 3 and 4 respectively. The ligand with the
lowest number of π-π stacking interactions (3) also had the most positive docking score. The
number of π-π stacking interactions increased to 6 as the alkyl chain was lengthened to a propyl
chain. This ligand, MGCS-175-073-3, had the most negative docking score of this group and the
highest number of hydrophobic residue interactions (21). The MGCS-175-073-5 ligand had
second most negative docking score and it also had 6 π-π stacking interactions. However, it only
had 20 hydrophobic interacting residues compared to the 21 with the MGCS-175-073-3 ligand.
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The MGCS-175-073-4 ligand had the most positive docking score. It also displayed the most
polar residues (4) of the group. No ligands in this group displayed hydrogen bonding interactions
or negatively charged residue interactions within a distance of 5 Å.
The JWH-073 group of ligands also has a N-linked butyl chain but also contains a
carbonyl group, methanone. The number of π-π stacking interactions in this group ranged from
1-6. The first three ligands, JWH-073, JWH-073-1, and JWH-073-2, all displayed 1 π-π stacking
interaction, 3 polar interactions, and 1 positively charged residue interactions within 5 Å. The
only difference in interactions between these first three ligands was the number of hydrophobic
residue interactions. JWH-073 and JWH-073-2 each had 19 hydrophobic interactions while
JWH-073-2, with the most positive docking score of the three ligands only had 17 hydrophobic
interactions. As the alkyl chain was lengthened to a propyl group these number of π-π stacking
interactions increased to 6 for the JWH-073-3 ligand. The JWH-073-3 ligand had the most
negative docking score of this group. It also had the highest number of π-π stacking interactions
(6) and the lowest number of hydrophobic interactions (13). It was the only ligand with 2
positively charged residues and the only ligand of this group to display hydrogen bonding within
5 Å. The JWH-073-4 ligand had the most positive docking score. It was observed to have 2 π-π
stacking interactions, 4 polar residues, 16 hydrophobic residues and only 1 positively charged
residue interaction. The docking score became slightly more negative as the butyl chain was
increased to a pentyl chain, JWH-073-5. The only difference observed between JWH-073-4 and
JWH-073-5 was the number of hydrophobic interactions, 16 and 17 respectively.
When comparing the interactions between the two groups of ligands it was observed that
the MGCS-175-073 group of ligands had more positive docking scores than the JWH-073 group
with the exception of MGCS-175-073-5 which was only slightly more negative than JWH-073-5.
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The MGCS-175-073 group has had a higher number of π-π stacking interactions, ranging from 36, while the JWH-073 group’s number of π-π stacking interactions stayed around 1 or 2 with the
only exception being JWH-073-3 that had 6 π-π stacking interactions. JWH -073-3 was also the
ligand with most negative docking score of both groups. It was also the ligand with the lowest
number of hydrophobic interactions, the only ligand with 2 positively charged residue
interactions and the only ligand with a hydrogen bond interaction. Based on this data it can be
determined that the presence of the methanone group (JWH-073) plays an important role in the
docking of synthetic cannabinoids to the CB1 receptor. 3D interaction diagrams were then used
to better examine the positions of the ligands in the binding pocket of the CB1 receptor. The
JWH-073 group of ligands were examined first using the 3D interaction diagram (Figure 13).

Figure 13. 3D interactions diagram of JWH-073 (green), JWH-073-1 (cyan), JWH-073-2 (pink),
JWH-073-3 (purple), JWH-073-4 (yellow), and JWH-073-5 (orange).
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In the JWH-073 group of ligands significant variation in the position of each ligand was
observed as the alkyl chain was lengthened on the naphthalene. However, when the MGCS-175073 group of ligands were examined, the ligands were found to be in similar positions even as
the alkyl chain was lengthened (Figure 14).

Figure 14. 3D interaction diagram of MGCS-175-073 (purple), MGCS-175-073-1 (green),
MGCS-175-073-2 (orange), MGCS-175-073-3 (pink), MGCS-175-073-4 (cyan), and MGCS175-073-5 (yellow).

The MGCS-175-073-2 and MGCS-175-073-4 ligands were found to be in very similar
positions. The variations in positions were observed in the alkyl chains of the structures (Figure
15).
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Figure 15. 3D interaction diagram of MGCS-175-073-2 (orange) and MGCS-175-073-4 (cyan).

MGCS-175-073-3 and MGCS-175-073-5 were observed to have similar positions to each
other, but where opposition of the MGCS-175-073-2 and MGCS-175-073-4 ligands (Figure 16).
The notable differences observed between the two ligands were in the position of their alkyl
chains in the binding pocket of the CB1 receptor.
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Figure 16. 3D interaction diagram of MGCS-175-073-3 (pink) and MGCS-175-073-5 (yellow).

2.3.2 JWH-175 and JWH-018
The next groups examined contained the parent structures JWH-175 and JWH-018. Both
of the groups contained a N-linked pentyl chain and the alkyl chain on the naphthalene was
increased to a five-carbon chain. The group starting with JWH-018 contains a carbonyl linker
(methanone) between the naphthalene and indole that is absent in the JWH-175 group.
As the alkyl chain was increased on the naphthalene, a trend was seen between both
groups in relation to their docking scores. (Figure 17) A methyl group was then added and both
groups saw an increase, becoming more positive, in docking score. The docking scores became
slightly more negative as the alkyl chain was increased to a two carbon, ethyl, chain. When a
propyl group was present the docking score became more negative for the JWH-175-3 ligand but
stayed around the same for the JWH-182 ligand. The docking scores observed from the addition
to a butyl chain, and the addition of a pentyl chain displayed more positive docking scores.
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However, overall the JWH-175 ligand group, with no carbonyl group, saw consistently better,
more negative docking scores with the exception of JWH-018. The most negative docking score
was observed for the JWH-018 ligand, while the JWH-018-5 ligand had the most positive
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Figure 17. Docking scores vs length of alkyl chain for the JWH-175 and JWH-018 groups.

To get a better understanding of how the structural characteristics of the ligands influence
the binding to the receptor, the specific residue interactions were examined. (Figure 18-19)
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Figure 18. Interacting residues observed within 5 Å for the JWH-175 ligand group.
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Figure 19. Interacting residues observed within 5 Å for the JWH-018 ligand group.

For the JWH-175 ligand group the number of π-π stacking interactions was between 3-6.
The JWH-175, JWH-175-1 and JWH-175-2 saw the least number of π-π stacking interactions,
only 3-4. The pattern in π-π stacking interactions for these three ligands correlates to their
docking scores, with the JWH-175-1 ligand having the leas number of π-π stacking interactions
(3) but the most negative docking score. These three ligands also had the lowest number of
hydrophobic residues compared to the ligands with the longer alkyl chains. As the alkyl chain
was lengthened to a propyl chain the number of π-π stacking interactions increased to 6, the same
was also seen for JWH-175-4. The JWH-175-5 ligand only had 5 π-π stacking interactions. This
increase in π-π stacking interactions correlates to the docking scores becoming more positive.
JWH-175-3 had the most negative docking score. This ligand had 6 π-π stacking interactions, 3
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polar, 20 hydrophobic and 1 positively charged residue interacting within 5 Å. JWH-175-3 had
the most hydrophobic residue interactions of the JWH-175 group. The JWH-175-5 ligand had
the post positive docking score and it had 5 π-π stacking interactions, 6 polar, 19 hydrophobic, 1
positively charged and 1 negatively charged residue interacting within 5 Å. This ligand had the
most polar residue interactions for this group. Negatively charged residues were only seen for
JWH-175-4 and JWH-175-5.
For the group of ligands starting with JWH-018, with the methanone group, the number
of π-π stacking interactions was between 2-3, significantly lower than the number of interactions
observed in the JWH-175 group (3-6). Similar to the JWH-175 group, the trend in docking
scores for JWH-018, JWH-122 and JWH-210 correlated to the number of π-π stacking
interactions observed; 3, 2, and 3 respectively. Of these three ligands the JWH-122 ligand had
the most positive docking score and the lowest number of π-π stacking interactions. JWH-018
had the most negative docking score of this group of ligands. This ligand also had the lowest
number of hydrophobic interactions (17) and displayed a hydrogen bond that was not present on
the other ligands. JWH-018-4 and JWH-018-4 were also the only ligands that displayed a
negatively charged residue within 5 Å. JWH-018-5 had the most positive docking score of this
group. This ligand had 2 π-π stacking interactions similar to JWH-122 and these ligands saw
similar docking scores, JWH-122 had a docking score of –7.598 and JWH-018-5 had a docking
score of –7.341. The difference in docking score between these two ligands can be explained by
the increased number of polar residues present for JWH-018-5. JWH-018-5 had 8 polar residues
while JWH-122 only had 5.
When comparing the interactions between the two groups of ligands it was observed that
the JWH-175 group, with no carbonyl, had more π-π stacking interactions. The JWH-018 group,
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however, had more polar residue interactions than the JWH-175 group. The JWH-175 ligands
were also found to have more negative docking scores with the exception of JWH-018. The
JWH-175 group of ligands all had 1 positively charged residue where the JWH-018 group all had
2. This could explain the more positive docking scores of the JWH-018 group. 3D interaction
diagrams were used to better understand the positions of the ligands in the binding pocket of the
CB1 receptor (Figure 20).

Figure 20. 3D interaction diagram of JWH-175 (pink), JWH-175-1 (yellow), JWH-175-2
(green), JWH-175-3 (cyan), JWH-175-4 (orange), and JWH-175-5 (purple).

In the 3D interaction diagram, it was observed that the ligands in the JWH-175 all
displayed similar positions in the binding pocket with the exception of JWH-175-4. All the
JWH-175 ligands were then examined without the addition of JWH-175-4 (Figure 21).
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Figure 21. 3D interaction diagram of JWH-175 (pink), JWH-175-1 (yellow), JWH-175-2
(green), JWH-175-3 (cyan), and JWH-175-5 (purple).

The 3D interaction diagram showed that the major differences observed in the positions
of the JWH-175 ligands was found in alkyl chains of each structure. The JWH-018 group was
also examined using the 3D interaction diagram (Figure 22).
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Figure 22. 3D interaction diagram of JWH-018 (yellow), JWH-122 (orange), JWH-210 (cyan),
JWH-182 (pink), JWH-018-4 (purple), and JWH-018-5 (green).

Unlike the JWH-175 group, the JWH-018 group was observed to have more variation in
positions of the structures in the binding pocket of the CB1 receptor. It can be assumed that it is
the presence of the carbonyl group in the JWH-018 group that influences the positions of each of
the ligands. Only two of the ligands from the JWH-018 group were found to have similar
positions, JWH-122 and JWH-210 (Figure 23).
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Figure 23. 3D interaction diagram of JWH-122 (orange) and JWH-210 (cyan).

Spectral data of the novel synthetic cannabinoid structures were generated using the
software ChemDoodle. ChemDoodle is able to produce 1H NMR and 13C NMR spectra of
compounds, as well as determine the mass parent peak (Figure 23).
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Figure 24. Spectral data of the novel synthetic cannabinoid MGCS-175-073; A) 1H NMR, B)
13C

NMR, C) Mass Parent Peak

2.4 Conclusions
The objective of this study was to examine known and novel synthetic cannabinoids from
the JWH family and how structural characteristics can influence docking and residue interactions
between the synthetic cannabinoids and the CB1 receptor. In this study the length of the alkyl
chain both on the naphthalene group was analyzed. The ligands in this study were examined in
two phases, each phase consisting of two groups of ligands. This was done to better understand
the influence certain structural characteristics have on the binding of the ligand to the CB1
receptor and what specific residues interactions are taking place. Trends were observed in each
group of ligands examined in the study when analyzing the docking scores and the number of
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interacting residues. It was determined that two structural characteristics were influential on the
docking of the ligands to the CB1 receptor, the carbonyl group between the naphthalene and the
indole and the length of the N-linked alkyl chain. 3D interaction diagrams were utilized to better
understand the influence of the structural characteristics on the position of the ligand in the
binding pocket of the CB1 receptor. Through the 3D interaction diagrams, it was determined that
the presence of a carbonyl group greatly impacts the positions of the ligands in the binding
pocket of the receptor. When there was not a carbonyl present (MGCS-175-073 and JWH-175),
the ligands were very similar in their positions. The length of alkyl chain on the naphthalene was
determined to influence the position of the alkyl chain; however, it did not appear to influence
the overall position of the ligand’s core structure in the CB1 receptor. Future studies will include
further analysis of what is influencing the varying positions in the core structures of the ligands
in the binding pocket of the CB1 receptor.
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CHAPTER 3
THE COMPUTATIONAL STUDY OF KNOWN AND NOVEL HALOGENATED
DERIVATIVES OF THE SYNTHETIC CANNABINOID JWH-018

3.1 Introduction
Synthetic cannabinoids are divided into families based on the structure and the designer
of the compound. The families include JWH-XXX, CP-XX,XXX, AM-XXX, HU-XXX, WINXXX and more. CP-XX,XXX synthetic cannabinoids were designed by Pfizer. The JWH-XXX
family of synthetic cannabinoids includes over 400 structures of cannabinoids that were designed
by John W. Huffman and his research group at Clemson University. Huffman’s compound JWH018 was one of the first synthetic cannabinoids marketed and sold as “Spice”. 38,39
JWH-018 has been known to have cannabimimetic, similar to cannabis, effects but in
lower doses than Δ9-THC. Δ9-THC is only a partial CB1 agonist.45 JWH-018 is a both a CB1 and
CB2 agonist, comparatively. In 2014 the European Monitoring Centre for Drugs and Drug
Addiction reported the finding of novel halogenated derivatives, JWH-018 Cl and JWH-018. It
has been noted that halogenation of cannabinoid structures can lead to substantial changes in
potency and affinity for the cannabinoid receptors.46
In 2015, Vigolo et al. studied these novel halogenated derivatives of JWH-018 through
examining multiple properties after acute exposure in mice and in vitro competition binding
experiments. The authors in this study determined that even though the halogenated derivatives
altered sensorimotor response in the mice like the parent compound, JWH-018, they showed
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fewer severe adverse effects. Vigolo et al. determined the rank order of potency to be JWH-018
> JWH-018 Cl > JWH-018 Br > Δ9-THC.46
The objectives of this study were to 1) investigate the binding properties of JWH-018 and
its known halogenated derivatives JWH-018 Cl and JWH-018 Br to the CB1 receptor and 2)
design the novel halogenated derivatives JWH-018 F and JWH-018 I and study their binding to
the CB1 receptor through the use of molecular docking.

JWH-018

JWH-018 Cl

JWH

Figure 25. Chemical structure of JWH-018, naphthalene-1-yl(1-pentyl-1H-indol-3-yl)methanone

3.2 Materials and Methods
Schrödinger’s molecular modeling software, Maestro, was
utilized F
to examine the
JWH-018
binding of JWH-018 and its known halogenated derivatives, JWH-018 Cl and JWH-018 Br, to
an active-state CB1 receptor model through molecular docking. Potential new halogenated
derivatives, JWH-018 F and JWH-018 I, were also analyzed in this study. Molecular docking is a
type of virtual screening that is able to place ligands of interest into the binding pocket of the
designated receptor in order to evaluate the binding affinity and ligand-receptor interactions. The
prepared 3-D active state model contains Δ9-THC in the binding pocket of the receptor. The
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JWH-018 I

three-dimensional (3D) homology model used in this study was designed and validated by the
Doerksen lab at The University of Mississippi, Department of BioMolecular Sciences, Division
of Medicinal Chemistry. Since the development of this model, a crystal structure has been
published. The crystal structure was published by Hua et al. in 2017.41 The Doerksen lab has
analyzed the crystal structure and compared it to the homology model and found only slight
differences in the two structures. The main difference to note is the LYS192 residue. In the
crystal structure the side chain of the LYS192 residue is outside the binding pocket, while in the
Doerksen model the side chain is pointing towards the binding pocket. It was decided that the
study would continue with use of the 3D homology model of the active-state CB1 receptor
developed by the Doerksen lab since both structures are comparable. The prepared 3-D active
state model contains Δ9-THC in the binding pocket of the receptor. (Figure 26)
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Figure 26. Validated 3D homology model of the active-state CB1 receptor, developed by the
Doerksen Lab, with a bound Δ9-THC ligand (P Pandey, K K Roy, R J Doerksen, unpublished).

3.2.1 Receptor Grid Generation
The Receptor Grid Generation application is used to accurately place a grid around the
binding pocket of the receptor. This was accomplished by selecting the Δ9-THC ligand already in
the binding pocket. The grid generated contained no constraints, rotatable groups and excluded
volumes applied to the receptor. The grid created was used to accurately dock the ligands of
interest to the receptor.
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3.2.2 Ligand Selection and Preparation
JWH-018 has two known halogenated derivatives, JWH-018 Cl and JWH-018 Br. For
this study all three of these structures were examined as well as the novel halogenated
derivatives JWH-018 F and JWH-018 I. The LigPrep protocol was used to successfully convert
ligands into three-dimensional structures. The preparation of the ligands involves generating
possible states at a target pH of 7.0 +/– 2.0 using Epik. Epik is used predict pKa values and
determine all chemically sensible structures.18,42

JWH-018

JWH-018 Cl

JWH-018 F

JWH-018 Br

JWH-018 I

Figure 27. Structures of known and novel halogenated derivatives of JWH-018.
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3.2.3 Ligand Docking
After the grid was generated and the desired ligands were prepared, the next step was
Glide Ligand Docking. This step allowed for the prepared ligands to be docked into the receptor
binding pocket selected during grid generation. Docking was completed using the standard
precision (SP) method and force field OPLS3. Flexible ligand sampling was selected and Epik
state penalties were added to the docking score. No constraints were selected to use in docking.
The Gide program is able to produce potential ligand conformations. The program uses a set of
ranked filters to find possible locations on the ligand in the binding pocket of the receptor. The
filters include; 1) side-point search, 2a) diameter test, 2b) subset test, 2c) greedy score, 2d)
refinement, 3) grid minimization, and 4) final scoring.43 The Glide Ligand Docking process is
described by Friesner et al. (2004).43 For each ligand, up to five possible poses were generated
and post-docking minimization was performed. The pose refers to the position and orientation of
the ligand in relation to the receptor.42 To determine the most accurate pose for each ligand, the
docking scores and Glide Emodel scores were analyzed. Docking scores are an estimation of the
binding free energy and are used to rank poses of different ligands. 43,44 The Glide Emodel was
used to compare poses and determine the best, or most likely, pose for each ligand. Docking
scores and Glide Emodel scores are negative. A more negative score means better docking. The
docking of each ligand, when using the same procedure, produces the same values. The
algorithm used by Glide does not require docking multiple times and will produce the same
values each time as long as the same procedure is used. The use of three decimal places is
because differences in some of the values between ligands might not have been seen until the
second or third decimal place. The software allows for more decimal places to be used, but it was
decided to use three decimal places due to some of the small changes observed in the data.
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3.2.4 Binding Energy Estimations: Prime MM-GBSA
The relative binding free energy of each ligand was then estimated using the Prime MMGSBA application and used the following the equation: MM-GBSA ΔGbind = E_complex
(minimized) – (E_ligand (minimized) – E_receptor (minimized)).22 The solvation model used
was VSGB and calculations were done using OPLS3. Protein flexibility was applied at a distance
of 5 Å from the ligand. The Prime MM-GBSA data values are not expected to be the same as the
experimental binding affinities. They are generated to give a ranking of the ligands that
correlates with the experimental data of binding affinities (Ki values). A more negative binding
free energy values correlates to a stronger binding.47
3.2.5 Spectral Simulation
Following the analysis of the known and novel synthetic cannabinoids, spectral data were
calculated for each of the new structures using spectral simulation software. The program
ChemDoodle was able to produce calculated 1H NMR, 13C NMR, and mass parent peak spectra
of the novel compounds. The known synthetic cannabinoids were also analyzed by this method
and compared to data from the NIST library to confirm accuracy.

3.3 Results and Discussion
Binding affinity studies of JWH-018 and its halogenated derivatives, JWH-018 Cl and
JWH-018 Br have been done with mouse brain membranes and human CB1 (hCB1)
membranes.46 In this study, the known halogenated derivatives and the novel halogenated
derivatives, JWH-018 F and JWH-018 I, were studied through the use of molecular docking.
Through molecular docking, the ligands were virtually docked to the 3D validated homology
model CB1 receptor developed by the Doerksen lab. Once the ligands were docked their docking
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scores were analyzed. The docking scores are estimation of the binding free energy and was used
to rank poses of different ligands. The lower, or more negative, the docking score is the stronger
the binding is to the CB1 receptor. When docked, each ligand produced up to five possible
poses. To determine the best pose of each ligand, the Glide Emodel value was used. The lowest,
or most negative, value indicates the best pose for that ligand. Binding energy calculations were
then done to determine the relative binding energy of the best pose of each ligand.

Table 1. Summary of experimental binding affinities, docking scores, glide Emodel values and
binding free energy estimations.
Ligand

JWH-018
JWH-018 F
JWH-018 Cl
JWH-018 Br
JWH-018 I

Mouse Brain
Membranes
Ki (nM)46*
5.82 + 0.61
4.21 + 0.49
7.13+ 0.62
-

hCB1 CHO
membranes
Ki (nM)46*
9.53 + 0.88
3.92 + 0.31
6.24 + 0.53
-

Docking
Scores
(kcal/mol)
–9.400
–7.337
–7.490
–7.470
–8.057

Glide
Emodel
–50.914
–44.240
–37.855
–54.988
–71.792

Binding
energy
(kcal/mol)
–54.416
–67.888
–74.287
–72.883
–75.725

*0.5 nM [3H]-CP-55,490 was used as the reference ligand for the competitive binding assay.46

The Ki values used for comparison in this study were calculated from competitive
binding experiments. The experiments performed by Vigolo et al. used 0.5 nM of [3H]-CP55,490 with both the mouse membranes and the human CB1 receptors. WIN-55,212-2 was added
to determine non-specific binding. The authors then determined the free and bound radioactivity.
Ki values, inhibitory binding constants, were calculated from the experimental IC50 values. The
IC50 values express what concentration of the ligand is required to inhibit half of the receptor’s
biological response. Vigolo et al. determined IC50 values through the use of cyclic AMP assays
where 0.5 nM 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724) was added to the
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hCB1 CHO membranes as a phosphodiesterase inhibitor. The Cheng and Prusoff equation was
used to determine the Ki values; Ki = IC50/(1+[C*]/KD*), C refers to the concentration of the
radioligand that was displaced and KD is the dissociation constant.46 The JWH-018 was found
to have the best, or most negative, docking score of all the ligands analyzed in this study. Its
docking score was determined to be –9.400 kcal/mol, followed by JWH-018 I, JWH-018 Cl,
JWH-018 Br and JWH-018F with –8.057, –7.490, –7.470, and –7.337 kcal/mol, respectively.
Binding free energy (kcal/mol) calculations were also done of the best pose for each ligand.
These values are not expected to be the same as the experimental binding affinities but are
expected to give a ranking of the ligands that correlates with the experimental data of binding
affinities (Ki). A more negative binding free energy value correlates to a stronger binding.35 This
data shows JWH-018 has the highest, most positive, binding free energy estimation (–54.416
kcal/mol), and it also has the highest experiment Ki value with hCB1 CHO (9.53 + 0.88 nM).
The only other Ki values available for comparison are for JWH-018 Br and JWH-018 Cl. JWH018 Cl had the lowest Ki value (3.92 + 0.31 nM) and the lowest, most negative binding free
energy ( –74.287 kcal/mol). JWH-018 Br fell in the middle with a Ki value of 6.24 + 0.53 nM
and binding energy estimation of –72.883 kcal/mol. The novel halogenated derivatives JWH-018
F and JWH-018 I do not have experimental Ki values, but they can be deduced based on the
estimated binding energies. It can be hypothesized that JWH-018 F would have a Ki value lower
than JWH-018, but higher than the other halogenated derivatives and JWH 018 I would have the
lowest, or better binding affinity, than all the other ligands.
Using the Ligand Interaction Diagram application in Maestro, the residues interacting at
within distance of 5 Å from the ligand were examined (Table 2). The types of interacting
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residues present within the binding pocket were labeled as hydrophobic, polar, negatively
charged or positively charged residues.

Table 2. Number and identification of interacting residues within 5 Å for JWH-018 and its
halogenated derivatives.
Ligand

JWH-018
JWH-018 F
JWH-018Cl
JWH-018Br
JWH-018 I

Docking
Binding
Score
Energy
(kcal/mol) (kcal/mol)
–9.401
–54.416
–7.337
–67.888
–7.490
–74.287
–7.470
–72.883
–8.057
–75.725

Hydrophobic

Polar

Negatively
Charged

Positively
Charged

17
21
22
21
21

6
4
4
7
6

1
1
1
1
1

2
1
1
1
1

It was determined that JWH-018, with the most negative docking score, possessed 17
hydrophobic residues, 6 polar residues, 1 negatively charged residue and 2 positively charged
residues. When comparing JWH-018 with its halogenated derivatives, it can be seen that some
of the major differences included the lower number of hydrophobic residues and the additional
positively charged residue for JWH-018. All ligands had the LYS192 residue present within 5 Å
and JWH-018 had both LYS192 and LYS376. The positively charged residue LYS376 only
appeared when the distance was adjusted for the halogenated derivatives to 6 Å. This could
indicate that the distance of specific residues from the ligand could impact the docking score and
overall binding of the ligand to the receptor. JWH-018 F and JWH-018 Cl were found to have
the least number of polar residues (4), but around the same number of hydrophobic residues as
the other halogenated derivatives, JWH-018 Br and JWH-018 I.
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After examining the residues present within the binding pocket, the direct interactions
taking place between the ligands and the CB1 receptor were analyzed. Interactions can include,
π-π stacking, hydrogen bonding, π-cation and salt bridges (Table 3).

Table 3. Residues interacting with the ligands CB1 receptor within the binding pocket within a
distance of 5 Å. Naphthalene 1is the benzene ring of the naphthalene connected to the carbonyl
group and naphthalene 2 is the benzene ring connected to naphthalene 1.
Ligand

π-π Stacking
Naphthalene 1

JWH-018

TRP279
TRP279

-

TRP279
TRP279

TRP279
TRP279

TRP356
PHE200

-

TRP279
TRP279

TRP279
TRP279

TRP356
PHE200

-

JWH-018 Br

PHE200
TRP356

PHE200

TRP279
TRP279

TRP279
TRP279

SER383

JWH-018 I

TRP356

PHE200

TRP279
TRP279

TRP279
TRP279

SER383

JWH-018 F

JWH-018 Cl

π-π Stacking
Naphthalene
2

π-π Stacking
Benzene
(Indole)
PHE177

π-π Stacking
Pyrrole
(Indole)

Hydrogen
Bond
TRP279

SER383

SER383

The only type of interactions seen between the ligands in this study and the CB1 receptor
were π-π stacking and hydrogen bonding. The one common interaction between all the ligands
was a π-π stacking interaction with TRP279. However, the location of this interaction on the
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ligand varied. The interacting residues between JWH-018 and the CB1 receptor included 2 π-π
stacking interactions with TRP279, 1 π-π stacking interaction with PHE177 and a hydrogen bond
between TRP279 and the oxygen of the carbonyl. JWH-018 F and JWH-018 Cl shared the same
interactions. Both ligands had 4 π-π stacking interactions with TRP279. Two of the π-π stacking
interactions were with the benzene ring connected to the carbonyl group (naphthalene 1) and the
other two were with the benzene ring connected to naphthalene 1 (naphthalene 2). There was
hydrogen bonding between SER383 and the double bonded oxygen of the carbonyl group. This
interaction with SER383 was seen in all the halogenated derivatives. JWH-018 Br and JWH-018
I had similar interactions. Each ligand had 4 π-π stacking interactions with TRP279, but, unlike
JWH-018 F and JWH-018 Cl the interactions were with the indole portion of the ligands. Of the
4 π-π stacking interactions with TRP279, 2 were interacting with the pyrrole of the indole and
the other 2 were with the benzene of the indole. There was a hydrogen bond between the oxygen
of the carbonyl and the SER383 residue. JWH-018 Br had 2 π-π stacking interactions with PHE
200, one interaction was on naphthalene 1 and the other was on naphthalene 2. JWH-018 Br also
had a π-π stacking interaction with TRP356 and naphthalene 1. JWH-018 I also had a π-π
stacking interaction with TRP356 and naphthalene 1. However, JWH-018 I only had 1 π-π
stacking interaction with PHE200 at the naphthalene 2 . Over all, the halogenated derivatives had
similar interacting residues. The parent structure, JWH-018, had less interactions and interacted
with different residues. While JWH-018 had a hydrogen bond between TRP279 and the double
bonded oxygen of the carbonyl, all the halogenated derivatives had hydrogen bonding with the
residue SER383. The halogenated derivatives overall had an increase in π-π stacking interactions
compared to JWH-018. These various differences could be responsible for the decreasing
docking scores of the halogenated derivatives from the parent structure, JWH-018. Although
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there were significant differences in docking scores between JWH-018 and its halogenated
derivatives, there was not a significant difference in docking scores between the individual
derivatives. These findings indicate that the added number of interactions taking place in the
binding pocket influences the docking score and binding of the ligands to the receptor.
Electronegativity could also be a factor in the binding of the halogenated derivatives to the CB1
receptor. Halogens are known to have high electronegativity. Electronegativity is defined as “ the
tendency of an atom to attract a bonding pair of electrons”.36 The periodic table shows the trend
of the electronegativity value of an element increases as it moves from left to right and increases
as it moves from the bottom to the top of the periodic table. The most electronegative of the
halogenated derivatives would be JWH-018 F, which also possess the highest, or least negative
docking score, –7.337 kcal/mol. JWH-018 I would be the least electronegative derivative and it
has the lowest, or most negative, docking score of –8.037 kcal/mol. JWH-018 Cl and JWH-018
Br have very close docking scores and also similar in electronegativity. To better understand the
interactions taking place between each ligand and the CB1 receptor, 3D interaction diagrams
were examined.
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Figure 28. 3D interaction diagram of JWH-018 (green) and all the halogenated derivatives;
JWH-018 F (cyan), JWH-018 Cl (pink), JWH-018 Br (yellow), and JWH-018 I (purple).

It was observed that JWH-018 differed greatly in its position in the binding pocket
compared to the halogenated derivatives. The position of the JWH-018 ligand explains why the
interactions varied between the ligand and its halogenated derivatives. JWH-018 contained π-π
stacking interactions with PHE177, a residue that was not observed in the derivatives, and
hydrogen bonding with TRP279 (Figure 29).
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Figure 29. 3D interaction diagram of JWH-018 and the PHE177 and TRP279 residues of the
CB1 receptor (shown as cartoon). Interacting residues are shown in grey.
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Figure 30. 3D interaction diagram of JWH-018 showing the distance from TRP279 (2.2 Å) and
SER383 (5.8 Å).

The halogenated derivatives of JWH-018 all displayed hydrogen bonding with SER383
where JWH-018 interacted with TRP279 through a hydrogen bond. Due to the position of JWH018 in relation to SER383, it was impossible for the ligand to interact with the residue. (Figure
30) The distance between the TRP279 residue and the carbonyl group of the JWH-018 ligand
involved in the hydrogen bonding was found to be 2.2 Å, where the SER383 residue was at a
distance of 5.8 Å. The positions of the halogenated derivatives were then compared to determine
what similarities and differences were found. (Figure 31)
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Figure 31. 3D interaction diagram of halogenated derivatives; JWH-018 F (cyan), JWH-018 Cl
(pink), JWH-018 Br (yellow), and JWH-018 I (purple).

From the 3D interaction diagram, it was observed that JWH-018 F and JWH-018 Cl had
similar positions and JWH-018 Br and JWH-018 I had similar positions. All of the halogenated
derivatives had π-π stacking interactions with TRP279, TRP356, and PHE200. However, the
interactions occurred on different locations of the ligand. The position of the JWH-018 F and
JWH-018 Cl ligands were opposite of the JWH-018 Br and JWH-018 I ligands.
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Figure 32. 3D interaction diagram with JWH-018 (green), JWH-018 F (cyan), and JWH-018 Cl
(pink).

JWH-018 F and JWH-018 Cl were found to be in similar positions in the binding pocket
of the CB1 receptor. The main difference was observed at the end of the alkyl chain where then
halogens were added. (Figure 32). The common residues observed between these two ligands
were examined (Figure 33).
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Figure 33. 3D interaction diagram of JWH-018 F (cyan) and JWH-018 Cl (pink) and the
interacting residues TRP279, TRP356, PHE200, and SER383 (grey).

Both the JWH-018 F and JWH-018 Cl ligand displayed π-π stacking interactions with
TRP279 and both benzenes of the naphthalene group. TRP356 and PHE200 interacted trough ππ stacking with the indole portion of each ligand. Hydrogen bonding was observed in both
ligands between SER383 and the carboxyl group. The JWH-018 Br and JWH-018 I ligands were
then examined (Figure 34-35).
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Figure 34. 3D interaction diagram with JWH-018 (green), JWH-018 Br (yellow), and JWH-018
I (purple).
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Figure 35. 3D interaction diagram of JWH-018 Br (yellow) and JWH-018 I (purple).

The JWH-018 Br and JWH-018 I ligands where found to be in very similar positions in
the binding pocket. Only slight differences were observed in the position of the alkyl chain with
the halogen added at the end. The interacting residues where the examined to better understand
how the position of the ligand influenced the residue interactions (Figure 36).
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Figure 36. 3D interaction diagram of JWH-018 Br (yellow) and JWH-018 I (purple) with the
interacting residues TRP279, TRP356, PHE200, and SER383.

JWH-018 Br and JWH-018 I interacted with the same residues as JWH-018 F and JWH018 Cl. However, the locations of the interactions were different. This is due to the position of the
JWH-018 Br and JWH-018 I ligands being opposite of the JWH-018 F and JWH-018 Cl ligands.
The software ChemDoodle was used to calculate spectral data of JWH-018 and its
halogenated derivatives. ChemDoodle is able to produce 1H NMR and 13C NMR spectra of
compounds, as well as determine the mass parent peak (Figure 37 - 41).
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Figure 37. Spectral data of JWH-018; A)1H NMR, B) 13C NMR and C)Mass Parent Peak.
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Figure 38. Spectral data of JWH-018 F; A)1H NMR, B) 13C NMR, and C)Mass Parent Peak.
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Figure 39. Spectral data of JWH-018 Cl; A)1H NMR, B) 13C NMR , and C)Mass Parent Peak.
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Figure 40. Spectral data of JWH-018 Br; A)1H NMR, B) 13C NMR , and C)Mass Parent Peak.

69

Figure 41. Spectral data of JWH-018 I; A)1H NMR, B) 13C NMR, and C)Mass Parent Peak.

3.4 Conclusions
This computational study of the known and novel halogenated derivatives of JWH-018
correlated to the rank of potency determined by Vigolo et al., JWH-018 > JWH-018 Cl > JWH018 Br through the docking scores of these structures. The novel halogenated derivatives of
JWH-018, JWH-018 F and JWH-018 I, were also examined in this study. The rank of potency
when compare to JWH-018 and its known halogenated derivatives was determined to be JWH018 > JWH-018 I > JWH-018 Cl > JWH-018 Br > JWH 018 F, based on docking scores.
Binding energy estimation calculations were also performed. The binding energy estimation
values are not expected to be the same as the experimental binding affinities but are intended to
give a ranking of the ligands that correlates with the experimental data of binding affinities.5647
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Experimental data showed that JWH-018 had the highest Ki value, which correlated to the
binding energy estimation. The experimental Ki values of JWH-018 Cl and JWH-018 Br also
aligned with the calculated binding energies. Based on the binding energy estimations, it can be
hypothesized that JWH-018 F would have a smaller Ki value than JWH-018 but a larger, or
weaker binding affinity, compared to the other halogenated derivatives. JWH-018 I can be
hypothesized to have the lowest, strongest binding, Ki value compared to all other ligands in this
study. Through 3D interaction diagrams it was observed that the position of JWH-018 inside the
binding pocket of the CB1 receptor differed greatly from its halogenated derivations which can
explain the differences in interacting residues and the differences in docking scores and binding
energy estimations. JWH-018 F and JWH-018 Cl where observed to be in similar positions in the
binding pocket, which correlates to the similarities seen in their interacting residues. JWH-018
Br and JWH-018 I were observed in opposite positions, compared to JWH-018 F and JWH-018
C, which is correlates to the differences in residue interactions. Future studies will further
examine the cause of varying positions of the core structures in the binding pocket of the CB1
receptor, to better understand the impact halogenation of synthetic cannabinoids has on the
binding.
Vigolo et al. hypothesized that the reason for the appearance of the halogenated
derivatives on the drug scene was to replace the parent compound, JWH-018.46 JWH-018 is
known to have severe adverse effects. The Vigolo et al. study shows there were not as many
severe side effects seen with the halogenated derivatives compared to JWH-018. To further
support Vigolo’s hypothesis, the novel halogenated derivatives in this study would need to be
synthesized and analyzed through in vitro and in vivo studies. The findings from this study

71

suggests that JWH-018 F would be the halogenated derivative that would produce less severe
side effects
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CHAPTER 4
THE COMPUTATIONAL STUDY OF KNOWN AND NOVEL HOMOLOGS OF
SYNTHETIC CANNABINOIDS IN THE CP FAMILY

4.1 Introduction
The CP-XX,XXX family of synthetic cannabinoids were developed by the company
Pfizer. Even though these compounds were developed in the 1970s and 1980s, only recently
have these compounds been seen in “spice” drugs on the street , as the synthetic cannabinoid
market has grown.48 Some CP-XX, XXX compounds, like CP-55,940, have been found to be
more potent than traditional marijuana and Δ9-THC. This is common with numerous synthetic
cannabinoids, even outside the CP-XX,XXX family. 49 There are only a few CP-XX,XXX
synthetic cannabinoids, three of the most prominent ones being CP-55,940, CP-47,497 and CP55,244. These three compounds have structural similarities. Each of these synthetic cannabinoids
contains a cyclohexanol group linked to a phenol group and a branched alkyl chain off the
phenol group as seen in CP-47,497. (Figure 28) CP-47,497 has known analogs where the length
of the phenol linked branched alkyl chain has been altered. The known analogs of CP-47,497
include (C6), (C8), and (C9) CP-47,497. The number following the carbon (C) indicates the
length of the phenol linked alkyl chain. These homologs of CP-47, 497 first appeared on the
market in Germany in 2009. The (C8) homolog, or 1,1-dimethyloctyl analog, was found to be
more potent than the parent compound, CP-47,497. Over the next two years following their
discovery, CP-47,497 and its analogs were made illegal in several countries including the U.S.50
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CP-47,497
Figure 42. Chemical Structure of CP-47,497.

The objectives of this study were to 1) analyze the compounds from the CP family of
synthetic cannabinoids and examine how they interact with the CB1 receptor through the use of
molecular docking and 2) examine the influence of the length of the phenol linked alkyl chain on
the binding to the CB1 receptor.

4.2 Materials and Methods
Schrödinger’s molecular modeling software, Maestro, was utilized to analyze a set of CPXX,XXX synthetic cannabinoids through molecular docking. Molecular docking is a type of
virtual screening that is able to place ligands of interest into the binding pocket of the designated
receptor in order to evaluate the binding affinity and ligand-receptor interactions.51 The prepared
3-D active state model contains Δ9-THC in the binding pocket of the receptor. The threedimensional (3D) homology model used in this study was designed and validated by the
Doerksen lab at The University of Mississippi, Department of BioMolecular Sciences, Division
of Medicinal Chemistry. Since the development of this model, a crystal structure has been
published. The crystal structure was published by Hua et al. in 2017.41 The Doerksen lab has
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analyzed the crystal structure and compared it to the homology model and found only slight
differences in the two structures. The main difference to note is the LYS192 residue. In the
crystal structure the side chain of the LYS192 residue is outside the binding pocket, while in the
Doerksen model the side chain is pointing towards the binding pocket. It was decided that the
study would continue with use of the 3D homology model of the active-state CB1 receptor
developed by the Doerksen lab since both structures are comparable. The prepared 3-D active
state model contains Δ9-THC in the binding pocket of the receptor. (Figure 43)

Figure 43. Validated 3D homology model of the active-state CB1 receptor, developed by the
Doerksen Lab, with a bound Δ9-THC ligand. (P Pandey, K K Roy, R J Doerksen, unpublished).
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4.2.1 Ligand Selection and Design
The focus of this study was the CP-XX,XXX family of synthetic cannabinoids. Three
cannabinoids were examined; CP-44,497, CP-55,244 and CP-55,940. These cannabinoids share a
common structural characteristic of a phenol linked, branched heptane chain, the phenol is
connected to a cyclohexanol group, but the structures vary on the substituent that is connected to
the cyclohexanol (Figure 44).

CP-47,497

CP-55,244

CP-55,490

Figure 44. Chemical structures of CP-47,497, CP-55,244 and CP-55,940.

The synthetic cannabinoid CP-44,497 has three known homologs including (C6), (C8),
and (C9)- CP-47,497. The number following the carbon (C) indicates the length of the phenol
linked alkyl chain. For this study the same homologs were analyzed for CP-55,940 and CP55,244. (Figure 45-47).
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(C6)-CP-47,497

(C7)-CP-47,497*
0

0

(C8)-CP-47,497

(C9)-CP-47,497

Figure 45. Structures of the CP-47,497 homologs. (C7)-CP-47,497* is the parent structure.
0
0

(C6)-CP-55,244

(C7)-CP-55,244*
0

0

(C8)-CP-55,244

(C9)-CP-55,244

Figure 46. Structures of the CP-55,244 homologs. (C7)-CP-55,244* is the parent structure.
0
0
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(C7)-CP-55,490*

(C6)-CP-55,490
0

(C9)-CP-55,490

(C8)-CP-55,490

Figure 47. Structures of the CP-55,490
0 homologs. (C7)-CP-55,490* is the parent structure.

4.2.2 Ligand Preparation
The LigPrep protocol is used to successfully convert ligands into three-dimensional
structures. The preparation of the ligands involves generating possible states at a target pH of 7.0
+/– 2.0 using Epik. Epik is used predict pKa values and determine all chemically sensible
structures.18,42
4.2.3 Receptor Grid Generation
The Receptor Grid Generation application is used to accurately place a grid around the
desired binding pocket of the receptor. This was achieved by selecting the Δ9-THC ligand
already in the binding pocket. The grid was generated without constraints, rotatable groups and
excluded volumes applied to the receptor. The grid created was used to accurately dock the
ligands into the binding pocket of interest in the CB1 receptor model.
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4.2.4 Ligand Docking
After the grid was generated and the desired ligands were prepared, the next step was
Glide Ligand Docking. This step allowed for the prepared ligands to be docked into the receptor
binding pocket selected during grid generation. Docking was completed using the standard
precision (SP) method and force field OPLS3. Flexible ligand sampling was selected and Epik
state penalties were added to the docking score. No constraints were selected to use in docking.
The Gide program is able to produce potential ligand conformations. The program uses a set of
ranked filters to find possible locations on the ligand in the binding pocket of the receptor. The
filters include; 1) side-point search, 2a) diameter test, 2b) subset test, 2c) greedy score, 2d)
refinement, 3) grid minimization, and 4) final scoring.43 The Glide Ligand Docking process is
described by Friesner et al. (2004).43 For each ligand, up to five possible poses were generated
and post-docking minimization was performed. The pose refers to the position and orientation of
the ligand in relation to the receptor.43 To determine the most accurate pose for each ligand, the
docking scores and Glide Emodel scores were analyzed. Docking scores are an estimation of the
binding free energy and are used to rank poses of different ligands. 43,44 The Glide Emodel was
used to compare poses and determine the best, or most likely, pose for each ligand. Docking
scores and Glide Emodel scores are negative. A more negative score means better docking. The
docking of each ligand, when using the same procedure, produces the same values. The
algorithm used by Glide does not require docking multiple times and will produce the same
values each time as long as the same procedure is used. The use of three decimal places is
because differences in some of the values between ligands might not have been seen until the
second or third decimal place. The software allows for more decimal places to be used, but it was
decided to use three decimal places due to some of the small changes observed in the data.
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4.2.5 Binding Energy Estimations: Prime MM-GBSA
The relative binding free energy of each ligand was then estimated using the Prime MMGSBA application. These calculations are done following the equation: MM-GBSA ΔGbind =
E_complex (minimized) – (E_ligand (minimized) – E_receptor (minimized)).22 The solvation
model used was VSGB and calculations were done using OPLS3. Protein flexibility was applied
at a distance of 5 Å from the ligand. The Prime MM-GBSA data values are not the expected to
be the same as the experimental binding affinities. They are generated to give a ranking of the
ligands that correlates with the experimental data of binding affinities (Ki values). A more
negative binding free energy value correlates to a stronger binding of the ligand to the receptor.47
4.2.6 Spectral Simulation
Following the analysis of the known and novel synthetic cannabinoids, spectral data were
calculated for each of the new structures using spectral simulation software. The program
ChemDoodle was able to produce 1H NMR, 13C NMR, and mass parent peak spectra of the novel
compounds. The known synthetic cannabinoids were also by this method and compared to data
from the NIST library to confirm accuracy.

4.3 Results and Discussion
The homologs of CP-47, 497 we first noted in the drug market in 2009 in Germany. In
this study we analyzed the known homologs of CP-47,497 and the novel homologs of similar CP
synthetic cannabinoids, CP-55,244 and CP-55,490. Through molecular docking the ligands were
virtually docked to the 3D validated homology model CB1 receptor developed by the Doerksen
lab. Once the ligands were docked their docking scores were analyzed. The docking scores are
estimation of the binding free energy and was used to rank poses of different ligands. The lower,
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or more negative, the docking scores correlate to stronger binding of the ligand to the CB1
receptor. Once docked, each ligand produced up to five possible poses. To determine the best
pose of each ligand, the Glide Emodel value was used. The lowest, or most negative, value
indicates the best pose for that ligand. Binding energy calculations were then done to determine
the relative binding energy of the best pose of each ligand.

Table 4. Summary of results showing experimental binding affinities, docking scores, glide
Emodel values and binding energy estimations.
Ligand

Docking Score
(kcal/mol)
–7.990

Glide Emodel

(C6)-CP-47,497

Ki
(nM)(50,52)**
-

–53.358

Binding energy
(kcal/mol)
–71.220

(C7)-CP-47,497*

2.20 + 0.5

–8.053

–54.956

–60.730

(C8)-CP-47,497

-

–8.151

–38.859

–59.640

(C9)-CP-47,497

-

–6.657

–36.772

–56.534

(C6)-CP-55,244

-

–7.521

–43.390

–82.542

(C7)-CP-55,244*

0.21 + 0.04

–7.265

–50.029

–77.262

(C8)-CP-55,244

-

–8.058

–27.336

–80.369

(C9)-CP-55,244

-

–7.688

–4.907

–69.6855

(C6)-CP-55,490

-

–8.256

–53.254

–72.067

(C7)-CP-55,490*

1.14 + 0.04

–9.011

–66.084

–72.133

(C8)-CP-55,490

-

–9.305

–56.443

–71.981

(C9)-CP-55,490

-

–8.361

–53.223

–72.957

*parent structure
**Ki determined from inhibition of adenylyl cyclase activity50
Ki determined from inhibition of radio ligand binding52
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The Ki, inhibitory binding constant, values for CP-47,497 and CP-55,490 used for
comparison in this were determined through competitive binding assays. 100 fmol/mL [3H]-CP55,490 was used by Melvin et al. as the radioligand to measure displacement. 100 nM of
desacetyllevonantradol was also added to the assay to determine non-specific binding. After
incubation and centrifugation, the free radioligand concentration was determined in the
supernatant of the sample and the bound ligand was calculated from the pellet. The authors used
linear regressions to determine the IC50 value, or the concentration of the ligand is required to
inhibit half of the receptor’s biological response. The Ki values was calculated using the Cheng
and Prusoff equation; Ki = IC50/(1+[C*]/KD*).50 The Ki value used for CP-55,244 was
determined by Griffin et al.52 The authors used the radioligand [3H]-SR141716A for the
competitive binding assays. The IC50 values were calculated by Griffin et al. through non-linear
regressions of the log concentration-percentage. Ki values were then determined using the Cheng
and Prusoff equation. 52 (C8)-CP-55.490 was found to have the best, or most negative, docking
score of all the ligands in this study. It was also discovered that in each group of homologs for
each ligand that the (C8) homolog always had the best, or most negative docking score. Previous
studies determined that the (C8) homolog of CP-47,497 was several times more potent than the
parent ligand.38 Based on the docking score it can be hypothesized that the same is true for the
other (C8) homologs. For the CP-47,497 group, the rank of docking scores was found to be
(C8) > (C7)* > (C6) > (C9). The rank of docking scores for CP-55,244 was determined to be
(C8) > (C9) > (C6) > (C7)* and for CP-55,490 the rank was (C8) > (C7)* > (C9) > (C6).
Binding free energy (kcal/mol) calculations were also done of the best pose for each
ligand. These values are not expected to be the same as the experimental binding affinities but
are expected to give a ranking of the ligands that aligns with the experimental data of binding
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affinities (Ki). A more negative binding free energy values correlates to a stronger binding. The
binding energy estimations calculated in this study correlated to the experiment Ki values of the
parent synthetic cannabinoids; the smaller Ki values correlated to more negative binding
energies. CP-47,497 (Ki= 2.1 nM) had a binding energy of -60.730 kcal/mol, CP-55,244 (Ki=
0.21 nM) had a binding energy of -77.262 kcal/mol and CP-55,490 (Ki = 0.58 nM) had a binding
energy of -72.133 kcal/mol. The rank of binding energy estimations for the parent synthetic
cannabinoids was determined to be CP-47,497 > CP-55,244 > CP-55,490, which is consistent
with the ranking order of Ki values. Based on this data it can be assumed that the Ki values of
each of the homologs will be ranked in this way; for CP-47,497: (C9) > (C8) > (C7) > (C6) , for
CP-55,244: (C9) > (C7)* > (C8) > (C6) and for CP-55,490: (C8) > (C6) > (C7) > (C9). Further
studies will need to be done to confirm this hypothesis.
Using the Ligand Interaction Diagram application in Maestro, the residues interacting
within a distance of 5 Å from the ligand were examined (Table 5). The types of interacting
residues present within the binding pocket were labeled as hydrophobic, polar, negatively
charged or positively charged residues.
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Table 5. Number and identification of residues interacting with each homolog
Ligand

Docking
score

Binding
energy

Hydrophobic

Polar

Negatively
Charged

Positively
Charged

(kcal/mol)

(kcal/mol)

(C6)-CP-47,497

–7.990

–71.220

21

5

1

-

(C7)-CP-47,497*

–8.053

–60.730

21

4

1

-

(C8)-CP-47,497

–8.151

–59.640

22

6

1

2

(C9)-CP-47,497

–6.657

–56.534

23

6

1

2

(C6)-CP-55,244

–7.521

–82.542

22

7

1

1

(C7)-CP-55,244*

–7.265

–77.262

24

7

1

1

(C8)-CP-55,244

–8.058

–80.369

23

7

1

1

(C9)-CP-55,244

–7.688

–69.6855

21

8

3

3

(C6)-CP-55,490

–8.256

–72.067

21

5

1

1

(C7)-CP-55,490*

–9.011

–72.133

21

5

1

1

(C8)-CP-55,490

–9.305

–71.981

21

6

1

1

(C9)-CP-55,490

–8.361

–72.957

21

6

1

1

All ligands had between 21 and 24 hydrophobic residues. A trend was seen in the polar
residues. The number of polar residues interacting in the binding pocket were at its highest when
the alkyl chains were increased to 8 and 9 carbons. There also was a correlation seen between Ki
values and polar residues. There were fewer polar residues (4) observed for CP-47,497 which
had the highest, weakest binding, Ki value (2.1 nM) compared to the 5 polar residues and a Ki
value of 0.58 nM for CP-55,490. CP-55,244 had the highest number of polar residues (7) and the
lowest, strongest binding, Ki value (0.21 nM). All ligands had the positively charged residue
LYS192 present, within a distance of 5 Å, in the binding pocket. However, (C8) and (C9)-CP-
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47,497 interacted with an additional residue, LYS376. (C9)-CP-55,244 had three positively
charged residues present within 5 Å; LYS192, LYS276 and ARG182. All the ligands that
contained a negatively charged residue shared the same negatively charged residue, ASP272.
Again, (C9)-CP-55,244 had three negatively charged residues; ASP272, GLU100 and GLU94.
For (C9)-CP-47,487 and (C9)-CP-55,244 there were additional residues present not listed in the
previous table. Both of these ligands had the GLY 99 residue present, which was not observed
with any other ligands within 5 Å, and (C9)-CP-47,487 possessed solvent exposure at the end of
the lengthened alkyl chain.
After examining the residues present within the binding pocket, the direct interactions
taking place between the ligands and the CB1 receptor were analyzed. Interactions can include,
π-π stacking, hydrogen bonding, π-cation and salt bridges. (Table 6)
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Table 6. Residues interacting with the ligands and the CB1 receptor within the binding pocket
within a distance of 5 Å
Ligand

π-π Stacking

Hydrogen Bond

(C6)-CP-47,497

TRP279
TRP279

LYS192

(C7)-CP-47,497*

TRP279
TRP279

-

(C8)-CP-47,497

TRP279
TRP279

PHE278

(C9)-CP-47,497

TRP279
TRP279

-

(C6)-CP-55,244

TRP279
TRP279

PHE278
VAL196

(C7)-CP-55,244*

TRP279
TRP279

PHE278

(C8)-CP-55,244

TRP279
TRP279

PHE278
VAL196

(C9)-CP-55,244

(C6)-CP-55,490

TRP279

PHE177
LYS376
THR377
TRP279

(C7)-CP-55,490*

TRP279

TRP279

(C8)-CP-55,490

TRP279

TRP279
LYS192

(C9)-CP-55,490

TRP279

TRP279

-
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The only types of interactions observed in this study was π-π stacking and hydrogen
bonding. All ligands, with the exception of (C9)-CP-55,244 displayed π-π stacking with the
TRP279 residue and the phenol group of the ligand. Even though (C9)-CP-55,244 did not have
any π-π stacking, it had the most hydrogen bonding. (C9)-CP-55,244 had the following three
hydrogen bonds: 1) PHE177 and the methanol group, 2) LYS376 and the hydroxyl of the phenol
group, and 3) THR377 with the hydroxyl of the cyclohexanol group. The CP-55,490 group only
contained one π-π stacking interaction with TRP279, while all the other ligands displayed two ππ stacking interactions with TRP279. (C7)-CP-47,497* and (C9)-CP-47,497 were the only
ligands that did not have any hydrogen bonding present. The (C6) and (C8) homolog ligands
each had 1 hydrogen bond present between the ligand and the receptor. (C6) had a hydrogen
bond present between LYS192 and the hydroxyl of the cyclohexanol and (C8) had a hydrogen
bond between PHE279 and the hydroxyl of the cyclohexanol. Every ligand in the CP-55,244
group displayed hydrogen bonding. (C6) had two instances of hydrogen bonding; PHE 278 with
the hydroxyl of the methanol group and VAL196 with the hydroxyl of the cyclohexane. (C7)CP-47,497* had only one hydrogen bond present between the hydroxyl of the methanol and
PHE278. Hydrogen bonding for the (C8) homolog was the same as the (C6); PHE278 with the
hydroxyl of the methanol group and VAL196 with the hydroxyl of the cyclohexane. (C9)-CP55,244, as mentioned previously, had three hydrogen bonds. The first hydrogen bond was with
PHE177 and the hydroxyl of methanol group, then LYS376 and the hydroxyl of the phenol, and
THR377 with the hydroxyl of the cyclohexanol. All of the CP-55,940 ligands in this study had
the same hydrogen bond with TRP279 and the hydroxyl of the propanol group. The (C8)
homolog had an addition hydrogen bonding instance with LYS192 and the hydroxyl of the
phenol group. This additional hydrogen bond for the (C8) homolog could be the catalyst for the
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better, more negative, docking score of this ligand compared to the other ligands in the CP55,490 group.
Following the analysis of the interacting residues, 3D interaction diagrams of the ligands
were examined to better understand how the position of the ligand in the binding pocket
influenced the docking and binding energy estimations.

Figure 48. 3D interaction diagram of CP-47,497 (green) and its homologs (C6)-CP-47,497
(pink), (C8)-CP-47,497 (cyan), and (C9)-CP-47,497 (yellow).
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The CP-47,497 set of ligands were all observed to varying positions in the binding pocket
of the CB1 receptor. The previous study by Melvin et al. was determined that the (C8) homolog
of CP-47,497 was more potent than its parent compound.50 The results of this study were found
to support the findings by Melvin et al. The 3D interaction diagrams of these two ligands were
further examined (Figure 49).

Figure 49. 3D interaction diagram of CP-47,497 (green) and (C8)-CP-47,497 (cyan).

The CP-47,497 ligand and its (C8) homolog where observed to be in very different
positions in the binding pocket of the CB1 receptor. The alkyl chains of each ligand were in
opposite directions of the binding pocket.
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Figure 50. 3D interaction diagram of CP-47,497 (green) and (C8)-CP-47,497 (cyan) and the
residues TRP279 and PHE278. PHE278 only interacted with (C8)-CP-47,497 (cyan) through a
hydrogen bond.

CP-47,497 and the (C8) homolog both interacted through π-π stacking with the residue
TRP279. However, the (C8) homology was found to have an addition interaction with PHE278
through hydrogen bonding. This hydrogen bonding was able to take place due to the position of
the (C8) homolog, which allows for the first hydroxyl group to be in close proximity to the
PHE278 residue in order to form that bond (Figure 51).
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Figure 51. 3D interaction diagram of CP-47,497 (green) and (C8)-CP-47,497 (cyan) and the
residue PHE278. PHE278 only interacted with (C8)-CP-47,497 (cyan) through a hydrogen bond
within a distance of 1.9 Å.

The variations in hydrophobic residues interacting with each homolog were then
examined to better understand the influence of increasing the alkyl chain and position of the
ligand in the binding pocket (Figure 52).
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Figure 52. 3D interaction diagram of CP-47,497 (green) and (C6)-CP-47,497 (pink).

CP-47,497 and the (C6) homolog were observed to be in similar positions in the binding
pocket. Differences were found in the position of the alkyl chain and the phenol group. CP47,497 and the (C6) homolog were found to interact with the same 21 hydrophobic residues;
LEU287, MET277, LEU286, MET363, PHE278, LEU360, PHE200, TRP356, LEU359,
TRP279, PHE379. ILE271, ALA383, PHE174, PHE177, LEU193, PHE189, VAL196, CYS386,
PHE170, AND VAL291. Both ligands displayed π-π stacking with TRP279, but the (C6)
homolog also displayed a hydrogen bond when LYS192. The position of the phenol group in the
(C6) homolog can explain this additional interaction of hydrogen bonding. The hydrogen bond
can also explain the better binding energy estimation calculated for the (C6) homolog compared
to the CP-47,497 parent structure.
After the CP-47,497 ligand, with a 7-carbon alkyl chain (C7), was increased to the (C8)
homolog, an increase in hydrophobic residue interactions was also observed.
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Figure 53. 3D interaction diagram of CP-47,497 (green) and (C8)-CP-47,497 (cyan) and the
hydrophobic residue PHE381. PHE381 was only observed with the (C8)-CP-47,497 (cyan).

The (C8) homolog of CP-47,497 was found to have 22 hydrophobic interactions,
compared to the 21 observed in the (C6) homolog and CP-47,497. The (C8) homolog had the
same 21 hydrophobic interactions but contained an addition hydrophobic residue, PHE381. The
PHE381 residue was observed near the end of the alkyl chain of the (C8) homolog. The number
of hydrophobic residues also increased as the alkyl chain was lengthened to the (C9) homolog, so
the variation in hydrophobic residues was further examined (Figure 54).
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Figure 54. 3D interaction diagram of CP-47,497 (green) its homologs (C6)-CP-47,497 (pink),
(C8)-CP-47,497 (cyan), and (C9)-CP-47,497 (yellow) shown with the hydrophobic residues
PHE381 and PHE102. PHE381 was observed in both the (C8) and (C9) homolog, and PHE102
was only observed for the (C9) homolog.

The (C9) homolog of CP-47,497 was found to have 23 hydrophobic interacting residues.
It was determined to have 21 hydrophobic residues in common with CP-47,497 and the (C6)
homolog and it had the same addition PHE 381 residue observed in (C8). The 23 rd residue was
determined to be PHE102. The location of this residue was found near the end of lengthened
alkyl chain of the (C9) homolog in the binding pocket of the CB1 receptor.
The CP-55,244 ligand and its homologs were then analyzed through 3D interaction
diagrams to better understand how the position of the ligand in the binding pocket influenced the
docking and binding energy estimations.
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Figure 55. 3D interaction diagram of CP-55,244 (pink) and its homologs (C6)-CP-55,244
(cyan), (C8)-CP-55,244 (yellow), and (C9)-CP-55,244 (green).

The position of CP-55,244 and its homologs in the binding pocket of the CB1 receptor
were analyzed through 3D interaction diagrams. CP-55,244 and its (C6) and (C8) homologs were
all in similar positions with only a few differences observed. The (C9) homolog, however, was
observed to be in a different location in the binding pocket. The location of the (C9) homolog
compared to the other CP-55,244 ligands explains the differences observed in the interacting
resides and its binding energy estimation.
The (C8) homolog of CP-55,244 was determined to have a better docking score and
binding energy estimation than CP-55,244. The 3D interaction diagram was used to compare CP55,244 and its (C8) homolog (Figure 56).
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Figure 56. 3D interaction diagram of CP-55,244 (pink) and (C8)-CP-55,244 (yellow).

CP-55,244 and the (C8) homolog displayed similar positions in the binding pocket of the
CB1 receptor. Some of the differences observed included the position of the hydroxyl groups.
The phenol group of the (C8) homolog was opposite of CP-55,244. There were also slight
differences in the position of the alkyl chain.

96

Figure 57. 3D interaction diagram of CP-55,244 (pink) and (C8)-CP-55,244 (yellow) and the
residues TRP279, PHE278 and VAL196. VAL196 only interacted with (C8)-CP-55,244
(yellow) through a hydrogen bond.

CP-55,244 and the (C8) homolog displayed π-π stacking interactions with TRP279 and
hydrogen bonding with PHE278. However, the (C8) homolog was the only one to have addition
hydrogen bonding occur with VAL196. It is possible that the CP-55,244 ligand did not interact
with VAL196 through hydrogen bonding due to the increased distance between the residue and
the nearest hydroxyl group of the ligand (Figure 58). The additional hydrogen bonding can
explain the better docking score and binding free energy estimation of the (C8) homolog.
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Figure 58. 3D interaction diagram of CP-55,244 (pink) and (C8)-CP-55,244 (yellow) and the
residue VAL196. VAL196 only interacted with (C8)-CP-55,244 (yellow) through a hydrogen
bond within a distance of 1.9 Å.

CP-55,244 and the (C6) homolog shared 22 hydrophobic interacting residues; LEU359,
LEU360, MET363, LEU286, TRP356, PHE200, ALA198, CYS386, PHE170, VAL196,
TRP279, LEU193, PHE177, PHE174, PHE189, PHE379, ALA380, ILE271, VAL291, MET277,
LEU287, AND PHE278. CP-55,244 also had two additional hydrophobic interacting residues,
ILE175 and LEU387. The length and the position of the CP-55,244 ligand in the binding pocket
can explain the additional hydrophobic residues observed (Figure 59).
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Figure 59. 3D interaction diagram of CP-55,244 (pink) and (C6)-CP-55,244 (cyan) and the
hydrophobic residues ILE175 and LEU387. ILE175 and LEU387 were only observed with CP55,244 (pink).

As the alkyl chain was lengthened to 8 carbons, the (C8) homolog, the number of
hydrophobic interactions observed was 23. The (C8) homolog had the same 21 hydrophobic
residues as CP-55,244 and the (C6) homolog. It also had the ILE175 hydrophobic residue present
like CP-55,244, but the LEU387 observed in CP-55,244 was not found to interact with the (C8)
homolog. The variations in hydrophobic interacting residues can be contributed to the lengths
and positions of the alkyl chains. (Figure 60) The (C9) homolog’s position in the binding pocket
was very different than the other ligands in the group. The (C9) homolog had 21 hydrophobic
interactions and of those 21, only 11 of the residues were the same as the other CP-55,244
ligands.
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Figure 60. 3D interaction diagram of CP-55,244 (pink), (C6)-CP-55,244 (cyan) and (C8)-CP55,244 (yellow) the hydrophobic residue ILE175. ILE175 was only observed with CP-55,244
(pink) and (C8)-CP-55,244 (yellow).

The CP-55,490 ligand and its homologs were then analyzed through 3D interaction
diagrams to better understand how the position of the ligand in the binding pocket influenced the
docking and binding energy estimations.
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Figure 61. 3D interaction diagram with CP-55,490 (purple), (C6)-CP-55,490 (green), (C8)-CP55,490 (orange), and (C9)-CP-55,490 (yellow).

CP-55,490 and its homologs were all observed to be in similar positions in the binding
pocket of the CB1 receptor through the 3D interaction diagram. Some differences observed were
in the position of the alkyl chain as it was lengthened and positions of the hydroxyl groups. As
seen in the other two groups of ligands, the (C8) homolog was determined to have a better
docking score than the CP-55,490 ligand. However, the binding free energy of the (C8) homolog
was slightly higher than the CP-55,490 ligand. CP-55,490 and the (C8) homolog were further
examined through 3D interaction diagrams (Figure 62).
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Figure 62. 3D interaction diagram with CP-55,490 (purple) and (C8)-CP-55,490 (orange).

The CP-55,490 ligand and its (C8) homolog were observed in similar positions in the
binding pocket of the CB1 receptor. Some of the differences observed were in the position of the
alkyl chain and the position of the hydroxyl group on the cyclohexanol.
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Figure 63. 3D interaction diagram with CP-55,490 (purple) and (C8)-CP-55,490 (orange) with
the residues TRP279 and LYS192. LYS192 was only observed interacting with (C8)-CP-55,490
(orange) through a hydrogen bond.

CP-55,490 and the (C8) homolog were found to interact through π-π stacking with
TRP279, and through a hydrogen bond with TRP279. The (C8) homolog was also observed to
have an additional hydrogen bond interaction with the residue LYS192. The difference in
position of the (C8) homolog compared to CP-55,490 allowed for the addition hydrogen bond to
occur with LYS192. The additional hydrogen bond can explain the better docking score of the
(C8) homolog, as was also seen in CP-47,497 group and the CP-55,244 group of ligands.
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The software ChemDoodle was used to calculate spectral data of the novel analogs
designed in this study. ChemDoodle is able to produce calculated 1H NMR and 13C NMR spectra
of the analogs, as well as determine the mass parent peak. (Figure 64-66)

Figure 64. Spectral data for CP-47,497; A) 1H NMR, B) 13C NMR, C) Mass Parent Peak.
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Figure 65. Spectral data for CP-55,244; A) 1H NMR, B) 13C NMR, C) Mass Parent Peak.

Figure 66. Spectral data for CP-55,490; A) 1H NMR, B) 13C NMR, C) Mass Parent Peak.
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4.4 Conclusions
This study examined the influence of alkyl chain length of known and novel homologs of
the CP synthetic cannabinoids, CP-47,497, CP-55,244 and CP-55,490. Three known homologs
of CP-47,497 exist; (C6), (C8) and (C9.) In this study each of the synthetic cannabinoids were
examined with (C6), (C8) and (C9) alkyl chains. A previous study determined that the known
(C8) homolog of CP-47,497 was several times more potent than the parent ligand. Melvin et al.
determined that (C8) and (C7) ligands of CP-47,497 showed the most affinity for the CB1
receptor compared to the other homologs of CP-47,497.50 The docking scores in this studied
showed that each of the (C8) homologs had the best, most negative, docking score in each group.
Based on the docking score (kcal/mol) it can be hypothesized that, like the (C8)-CP-47,497
homologs, the other (C8) homologs could be more potent than their parent structure. For the CP47,497 group, the rank of docking scores was found to be (C9) > (C6) > (C7)* > (C8). Based on
rank of docking score, the results of this study support those found in the study by Melvin et al.59
The rank of docking scores for CP-55,244 was determined to be (C7)* > (C6) > (C9) > (C8) and
for CP-55,490 the rank was (C6) > (C9) > (C7)* > (C8). The binding energy estimations
calculated in this study correlated to the experiment Ki values of the parent synthetic
cannabinoids. The rank of binding energy estimations for the parent synthetic cannabinoids was
determined to be CP-47,497 > CP-55,244 > CP-55,490. Based on this data it can be
hypothesized that the binding affinity values of each of the homologs will be ranked as the
following; for CP-47,497: (C9) > (C8) > (C7)* > (C6) , for CP-55,244: (C9) > (C7)* > (C8) >
(C6) and for CP-55,490: (C8) > (C6) > (C7)* > (C9). Interacting residues were examined and it
was determined that π-π stacking interactions and hydrogen bond interactions are essential to
better docking of the ligands to the CB1 receptor. The position of each of the (C8) homologs
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allowed for addition hydrogen bonding that was not observed in the parent ligand. The varying
positions of the core structures of the ligands in the binding pocket of the CB1 receptor will be
examined in future studies. More variation of the core structure was observed with the CP47,497 group of homologs compared to the other groups examined in this study. Future studies
will work to determine what is influencing the different positions in the binding pocket of the
CB1 receptor observed in this study.
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CHAPTER 5
THE COMPUTATIONAL STUDY OF KNOWN AND NOVEL FENTANYL ANALOGS
AND THE MU-OPIOID RECEPTOR

5.1 Introduction
Fentanyl was synthesized in 1960 by Dr. Paul Janssen of the Janssen Company to act as a
rapid-acting analgesic. Unlike similar analgesics around that time, fentanyl did not have negative
cardiovascular effects.53 Fentanyl overdoses began to be reported around 1972, with the misuse
being reported in increasing frequency as additional methods of administration became
available.53 From 1999 to 2011, the number of fatal opioid analgesic overdoses quadrupled and,
for the year 2015, the death toll in the United States totaled 33,091.54 One reason for this spike in
overdose deaths is the now common practice by drug dealers of lacing heroin with fentanyl in
order to increase their client’s opioid high. In addition to the United States’ regulation of fentanyl
and various fentanyl derivatives, other countries are attempting to gain control of this epidemic
as well. Unfortunately, as soon as a country has regulated a certain type of fentanyl, another
comparable compound can be found on the market; causing fentanyl overdose deaths to likely be
highly underreported.54 Due to these factors, it is of utmost importance not only understand
fentanyl itself, but to also understand several different fentanyl derivatives and how they interact
with opioid receptors in the human body. Fentanyl and its derivatives are all agonists at the muopioid receptors. There are several physical effects of opioid binding at the mu-opioid receptor;
including respiratory and central nervous system depression. 54 In fact, this respiratory depression
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is what usually leads to fatality in a fentanyl overdose. Fentanyl related deaths are
increasing, and more fentanyl derivatives are appearing in the drug market, some more potent
than itspredecessors. It is therefore imperative that the criminal justice community stay ahead of
the illegal drug market. This can be accomplished by using computational methods to investigate
ligand binding of illegal substances to their corresponding receptors before they make it into the
market for recreational use.
The objectives of this study were to 1) analyze the binding of fentanyl and fentanyl
analogs to the mu-opioid receptor through the use of molecular docking and 2) design and study
potentially new fentanyl analogs and how various structural characteristics can influence
binding. Once the newly designed analogs were analyzed, spectral data were calculated to begin
compiling information for the development of a database.
5.2 Materials and Methods
Schrödinger’s molecular modeling software, Maestro, was used to examine the binding
of select fentanyl analogs, and designed potential analogs, to the mu-opioid receptor. The muopioid receptor used in this study was prepared from the crystal structure, PDB:5C1M,
developed by Huang et al.41
5.2.1 Ligand Selection and Design
The focus of this study was to analyze known and novel fentanyl analogs. The novel
fentanyl analogs were designed using the known analogs. Based on structural characteristics of
the known analogs, new analogs were designed. The known analogs examined in this study
included N-methyl fentanyl, fentanyl, and carfentanyl. The novel analogs were designed in two
sets; 1) from the parent N-methyl fentanyl and fentanyl and 2) from the parent carfentanyl analog
(Figure 67-68).
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N-methyl fentanyl*

N-ethyl fentanyl

N-propyl fentanyl

Fentanyl*

Figure 67. Structures of N-methyl fentanyl, N-ethyl fentanyl, N-propyl fentanyl, and fentanyl.

Carfentanyl (methyl)

Carfentanyl (ethyl)

Carfentanyl *

Carfentanyl (carboxylic acid)

Carfentanyl (aldehyde)

Carfentanyl (ketone)

Figure 68. Structures of the designed carfetanyl analogs and the parent structure of carfentanyl.
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5.2.2 Ligand Preparation
The LigPrep protocol is used to successfully convert ligands into three-dimensional
structures. The preparation of the ligands involves generating possible states at a target pH of 7.0
+/– 2.0 using Epik. Epik is used predict pKa values and determine all chemically sensible
structures.18,42
5.2.3 Protein Preparation
The Protein Preparation application is used to covert the imported PDB file of 5C1M to
a prepared model ready for docking. In order to prepare the mu-opioid receptor the following
steps were taken. Once the PDB file “5C1M” was imported, the modified residue within the
sequence was changed to its proper residue. This information was found within the Protein Data
Bank. The modified residue present in 5C1M was YCM, S-(2-amino-2-oxoethyl)-L-cysteine,
which was changed to the parent residue, cysteine (CYS). In the workspace the B chain and all
the groups present, except 4VO, the co-crystallized ligand, were deleted. For preprocess all
original hydrogens were removed, waters beyond 5 Å from co-crystallized ligand were deleted
and protonation states were generated using Epik with a pH of 7.0 +/- 2.0. To refine the protein,
the first step was optimization of H-bond assignment, which was done with sampling water
orientations, using crystal symmetry and minimizing hydrogens of altered species. PROPKA was
used at a pH of 7.0, PROPKA predicts Ka values of protein residues. Waters with less than 2
hydrogen bonds to non-waters were then removed. Minimization was performed converging
heavy atoms to a distance of 0.30 Å with, hydrogens atoms minimized, using the force field
OPLS3.
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5.2.4 Receptor Grid Generation
The Receptor Grid Generation application is used to accurately place a grid around the
binding pocket of the receptor. The structure present in the mu-opioid receptor model to generate
the grid was 4VO. For this receptor there were no constraints but a rotatable group, TYR148 was
selected for grid generation. The force field used was OPLS3. The grid created was used to
accurately dock the ligands of interest to the receptor.
5.2.5 Ligand Docking
After the grid was generated and the desired ligands were prepared, the next step was
Glide Ligand Docking. This step allowed for the prepared ligands to be docked into the receptor
binding pocket selected during grid generation. Docking was completed using the standard
precision (SP) method and force field OPLS3. Flexible ligand sampling was selected and Epik
state penalties were added to the docking score. No constraints were selected to use in docking.
The Gide program is able to produce potential ligand conformations. The program uses a set of
ranked filters to find possible locations on the ligand in the binding pocket of the receptor. The
filters include; 1) side-point search, 2a) diameter test, 2b) subset test, 2c) greedy score, 2d)
refinement, 3) grid minimization, and 4) final scoring.43 The Glide Ligand Docking process is
described by Friesner et al. (2004).43 For each ligand, up to five possible poses were generated
and post-docking minimization was performed. The pose refers to the position and orientation of
the ligand in relation to the receptor.43 To determine the most accurate pose for each ligand, the
docking scores and Glide Emodel scores were analyzed. Docking scores are an estimation of the
binding free energy and are used to rank poses of different ligands. 43,44 The Glide Emodel was
used to compare poses and determine the best, or most likely, pose for each ligand. Docking
scores and Glide Emodel scores are negative. A more negative score means better docking. The
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docking of each ligand, when using the same procedure, produces the same values. The
algorithm used by Glide does not require docking multiple times and will produce the same
values each time as long as the same procedure is used. The use of two and three decimal places
is because differences in some of the values between ligands might not have been seen until the
second or third decimal place. The software allows for more decimal places to be used, but it was
decided to use two and three decimal places due to some of the small changes observed in the
data.
5.2.6 Binding Energy Estimations: Prime MM-GBSA
The relative binding free energy of each ligand was estimated using the Prime MM-GSBA
application. These calculations are done following the equation: MM-GBSA ΔGbind = E_complex
(minimized) – (E_ligand (minimized) – E_receptor (minimized)).22 The solvation model used
was VSGB and calculations were done using OPLS3. Protein flexibility was applied within a
distance of 5 Å from the ligand. The Prime MM-GBSA data values are not expected to be the
same as the experimental binding affinities but are expected to give a ranking of the ligands that
correlates with the experimental data of binding affinities (Ki values). A more negative binding
free energy value correlates to a stronger binding of the ligand to the receptor. 47
5.2.7 Spectral Simulation
Following the analysis of the known and novel fentanyl analogs, spectral data were
calculated for each of the new structures using spectral simulation software. The program
ChemDoodle was able to produce 1H NMR, 13C NMR, and mass parent peak spectra of the novel
compounds. The known synthetic cannabinoids were also analyzed by this method and compared
to data from the NIST library to confirm accuracy.
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5.3 Results and Discussion
In this study known and novel fentanyl analogs and their binding to the mu-opioid
receptor were analyzed. Through molecular docking the ligands were virtually docked to the 3D
model of the mu-opioid receptor. The mu opioid receptor was prepared from the crystal structure
developed by Huang et al., PDB: 5C1M.55 Once the ligands were docked their docking scores
were analyzed. The docking scores are estimations of the binding free energy and were used to
rank poses of different ligands. The lower, or more negative, the docking score is the stronger the
binding is to the receptor. When docked, each ligand produced up to five possible poses. To
determine the best pose of each ligand, the Glide Emodel value was used. The lowest, or most
negative, value indicates the best pose for that ligand. Binding energy calculations were then
done to determine the relative binding energy of the best pose of each ligand.
5.3.1 Fentanyl Analogs
The first set of known and novel fentanyl analogs were N-methyl fentanyl, N-ethyl
fentanyl, N-propyl fentanyl and fentanyl itself. The parent structures in this group are N-methyl
fentanyl and fentanyl. N-ethyl and N-propyl fentanyl were designed to examine how the binding
of the ligands changed as N-methyl fentanyl grew into fentanyl. (Figure 37)
The ligands were virtually docked into the prepared mu-opioid receptor using the molecular
docking software Maestro. Once the ligands were docked their docking scores were analyzed.
The docking scores are estimation of the binding free energy and was used to rank poses of
different ligands. The lower, or more negative, the docking scores correlate to stronger binding
of the ligand to the CB1 receptor. Once docked, each ligand produced up to five possible poses.
To determine the best pose of each ligand, the Glide Emodel value was used. The lowest, or most
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negative, value indicates the best pose for that ligand. Binding energy calculations were then
done to determine the relative binding energy of the best pose of each ligand.

Table 7. Summary of experimental binding affinities, docking scores, glide Emodel values, and
binding free energy estimations. The Ki values for N-methyl fentanyl and fentanyl are from
experimental data from guinea pig brain membranes. 56
Ligand

Docking
Score
(kcal/mol)
–5.742

Glide Emodel

Binding Energy
(kcal/mol)

N-methyl fentanyl *

Binding
Affinity
Ki (nM)(56)**
18000 + 3000

–50.799

–41.971

N-ethyl fentanyl

-

–5.476

–49.824

–45.155

N-propyl fentanyl

-

–5.333

–51. 778

–49.467

Fentanyl*

1.2 + 0.2

–6.870

–61.318

–54.073

*parent structure
**Inhibition of [3H]DAGO ( [D-Ala2, MePhe4, Gly5-ol]encephalin) was determined.56

The experimental Ki values used for comparison in this study were determined through
competitive binding assays by Maguire et al.56 The radioligand [D-Ala2, MePhe4, Gly5ol]encephalin was used to measure displacement and determine the IC 50 value. IC50 values
determine the concentration of the ligand is required to inhibit half of the receptor’s biological
response. Maguire et al. used linear regression to calculate the IC50 values. To determine the Ki
values from the IC50 values, the authors used a program known as LIGAND.57 This
computational program analyzed the competitive binding assay data to determine the Ki values. 57
The parent compound fentanyl was found to have the best, most negative docking score
(-6.870). Fentanyl also had the most negative binding affinity, -54. kcal/mol. The rank of

115

docking scores of these analogs was determined to be N-propyl fentanyl > N-ethyl fentanyl > Nmethyl fentanyl > fentanyl. The rank of the binding affinities was determined to be N-methyl
fentanyl > N-ethyl fentanyl > N-propyl fentanyl > fentanyl. The binding free energy estimations,
while not identical to the Ki values, is expected to be similar in rank. Therefore, it can be
assumed that the novel ligands N-ethyl fentanyl and N-propyl fentanyl will have larger Ki values
than fentanyl but smaller than N-methyl fentanyl.
Using the 2D Ligand Interaction Diagram application in Maestro, the residues interacting
within a distance of 5 Å from the ligand were examined (Table 8). The types of interacting
residues present within the binding pocket were labeled as hydrophobic, polar, negatively
charged, and positively charged residues.

Table 8. Number and identification of interacting residues within 5 Å.
Ligand

Docking
score
(kcal/mol)
–5.742

Binding
energy
(kcal/mol)
–41.971

Hydrophobic

Polar

Negatively
Charged

Positively
Charged

14

4

1

0

–5.476

–45.155

16

5

1

0

N-propyl fentanyl

–5.333

–49.467

20

5

1

0

Fentanyl*

–6.870

–54.073

21

6

1

1

N-methyl
fentanyl*
N-ethyl fentanyl

There were a few trends observed when analyzing the residues interacting within a
distance of 5 Å. There was a correlation observed between the binding energy estimations and
hydrophobic interactions, as well as the polar residue interactions. As N-methyl fentanyl
transitioned into fentanyl, the binding energy estimations became more negative and the number
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of hydrophobic and polar residue interactions increased. All the ligands contained 1 negatively
charged residue, but fentanyl was the only ligand with a positively charged residue present in the
binding pocket within 5 Å. The docking scores of N-ethyl and N-propyl fentanyl were more
positive and they contained increased number of hydrophobic and polar residues compared to the
parent analog N-methyl fentanyl. However, the transition from N-propyl fentanyl to fentanyl
resulted in a large decrease, becoming more negative, docking score. This increase in docking
can be contributed to the additional positively charged residue not seen in the other ligands.
However, it is essential to analyze the direct interactions taking place as well. After examining
the residues present within the binding pocket, the direct interactions between the analogs and
the mu-opioid receptor were analyzed. Interactions can include π-π stacking, π-cation, hydrogen
bonding, and salt bridges.

Table 9. Residues interacting with the analogs within a distance of 5 Å.
Ligand

Salt Bridge Hydrogen Bond

π-π Stacking

π-Cation

N-methyl fentanyl *

ASP147

ASP147

TRP293

-

N-ethyl fentanyl

ASP147

ASP147

TRP293

-

N-propyl fentanyl

ASP147

ASP147

-

-

Fentanyl*

ASP147

ASP147

TRP293,
TYR326

-

Each analog ligand examined contained a salt bridge with ASP147 and a hydrogen bond
ASP147. The interactions with ASP147 and each ligand was found to occur between the
protonated nitrogen of the cyclohexane group and the residue. π-π stacking interactions were
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seen for every ligand except N-propyl fentanyl. N-propyl fentanyl also had the most positive
docking score, indicating that π-π stacking is essential to have better docking of the analogs to
the mu-opioid receptor. Fentanyl was the only ligand in this group that contained two π-π
stacking interactions, one with TRP293 and an additional interaction with TYR326. Fentanyl
also had the most negative docking score. Again, this indicated that π-π stacking is essential to
the strong binding of the analogs to the mu-opioid receptor. No π-cation interactions were seen in
this group of ligands. 3D interaction diagrams were examined to gain of better understanding of
the position of each ligand in the binding pocket.

Figure 69. 3D interaction diagram of N-methyl fentanyl (green), N-ethyl fentanyl (cyan), Npropyl fentanyl (pink), and fentanyl (grey).
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The N-methyl fentanyl, N-ethyl fentanyl, and N-propyl fentanyl ligands were all
observed to be in similar positions. The position of the fentanyl was found to be the most
different compared to the other ligands. The ligands with the best docking scores were N-methyl
fentanyl and fentanyl (Figure 70).

Figure 70. 3D interaction diagram of N-methyl fentanyl (green) and fentanyl (grey).

All ligands in this group were observed interacting with the ASP147 residue through both
a salt bridge and a hydrogen bond ( Figure 71).
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Figure 71. 3D interaction diagram of N-methyl fentanyl (green), N-ethyl fentanyl (cyan), Npropyl fentanyl (pink), and fentanyl (grey) with the ASP147 residue.

TRP 293 was only found to interact with three of the ligands in this group, N-methyl
fentanyl, N-ethyl fentanyl, and fentanyl (Figure 72).
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Figure 72. 3D interaction diagram of N-methyl fentanyl (green), N-ethyl fentanyl (cyan), and
fentanyl (grey) with the ASP147 residue and the TRP293 residue.

N-methyl fentanyl, N-ethyl fentanyl and fentanyl displayed a salt bridge and hydrogen
bonding with ASP147, as well as π-π stacking with TRP293. The distance between the benzene
group of the ligands and the TRP293 could be assumed to influence the over docking of the
ligand. The benzene of the fentanyl interacting with the TRP293 residue was observed to be in
closer proximity to the residue than the N-methyl and N-ethyl fentanyl ligands. Fentanyl was
also observed to have an addition π-π stacking interaction with TYR326 (Figure 73).
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Figure 73. 3D interaction diagram of fentanyl (grey) with the residues TRP293, TYR326 and
ASP147.

The fentanyl ligand was the only ligand in the group to have two π-π stacking
interactions, one with TRP293 and one with TYR326. The position of the fentanyl ligand in the
binding pocket of the mu-opioid receptor allowed for the addition interaction to occur. Fentanyl
was also determined to have the best docking score and the best binding energy estimation.

5.3.2 Carfentanyl Analogs
The second set of known and novel fentanyl analogs were designed from the parent
analog. (Figure 38) The structural differences in the analogs took place at C4 of the piperidine
ring, in the para position to the nitrogen. The analogs were virtually docked into the prepared
mu-opioid receptor using the molecular docking software Maestro. Once the ligands were
docked their docking scores were analyzed. The docking scores are estimation of the binding
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free energy and was used to rank poses of different ligands. The lower, or more negative, the
docking scores correlate to stronger binding of the ligand to the CB1 receptor. Once docked,
each ligand produced up to five possible poses. To determine the best pose of each ligand, the
Glide Emodel value was used. The lowest, or most negative, value indicates the best pose for
that ligand. Binding energy calculations were then done to determine the relative binding energy
of the best pose of each ligand.

Table 10. Summary of experimental binding affinities, docking scores, glide Emodel values, and
binding free energy estimations. The Ki values provided for carfentanyl and lofentanyl are
experimental data from guinea pig brain membranes. 56
Ligand

Docking
Score
(kcal/mol)
–6.611

Glide
Emodel

Carfentanyl (methyl)

Binding
Affinity
Ki(nM)(56)**
-

–63.161

Binding
Energy
(kcal/mol)
–52.512

Carfentanyl (ethyl)

-

–7.023

–63.890

–61.265

Carfentanyl (aldehyde)

-

–6.937

–64.384

–59.450

Carfentanyl (ketone)

-

–7.080

–59.307

–59.104

Carfentanyl (carboxylic
acid)
Carfentanyl*

-

–6.702

–58.704

–42.687

0.024 + 0.004

–7.182

–68.850

–60.126

*parent structure
**Inhibition of [3H]DAGO ([D-Ala2, MePhe4, Gly5-ol]encephalin) was determined.56

The experimental Ki values used for comparison in this study were determined through
competitive binding assays by Maguire et al.56 The radioligand [D-Ala2, MePhe4, Gly5ol]encephalin was used to measure displacement and determine the IC 50 value. IC50 values
determined the concentration of the ligand is required to inhibit half of the receptor’s biological
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response. Maguire et al used linear regression to calculate the IC50 values. To determine the Ki
values from the IC50 values, the authors used a program known as LIGAND.57 This
computational program analyzed the competitive binding assay data to determine the Ki values. 57
In this group of known and novel fentanyl analogs, carfentanyl was found to have the
most negative docking score while the novel ligand carfentanyl (methyl) had the most positive
docking score. The rank of docking scores was determined to be carfentanyl (methyl) >
carfentanyl (carboxylic acid) > carfentanyl (aldehyde) > carfentanyl (ethyl) > carfentanyl
(ketone) > carfentanyl. The most negative binding energy estimation was for the ligand
carfentanyl (ethyl), which was only slightly more negative than the parent analog carfentanyl.
The rank of binding free energy estimations was found to be carfentanyl (carboxylic acid) >
carfentanyl (methyl) > carfentanyl (ketone) > carfentanyl (aldehyde) > carfentanyl > carfentanyl
(ethyl). Therefore, it can be expected that carfentanyl (ethyl) would have a smaller binding
affinity than carfentanyl, correlating to a stronger binding. The other novel analogs are expected
to have a larger binding affinity for the mu-opioid receptor, weaker binding, compared to
carfentanyl.
Using the 2D Ligand Interaction Diagram application in Maestro, the residues interacting
within a distance of 5 Å from the ligand were examined (Table 11). The types of interacting
residues present within the binding pocket were labeled as hydrophobic, polar, negatively
charged, and positively charged residues.
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Table 11. Number and identification of interacting residues within 5 Å.
Ligand

Docking
score

Binding
energy

Hydrophobic

Polar

Negatively
Charged

Positively
Charged

(kcal/mol)

(kcal/mol)

Carfentanyl
(methyl)

–6.611

–52.512

16

6

1

1

Carfentanyl
(ethyl)

–7.023

–61.265

21

6

1

1

Carfentanyl
(aldehyde)

–6.937

–59.450

17

7

1

2

Carfentanyl
(ketone)

–7.080

–59.104

20

5

1

0

Carfentanyl
(carboxylic
acid)

–6.702

–42.687

20

6

1

0

Carfentanyl*

–7.182

–60.126

21

6

1

1

The analogs carfentanyl and carfentanyl (ethyl) have the highest number of hydrophobic
residue interactions (21) and also some of the more negative docking scores and the most
negative binding energy estimations. These two ligands also had 6 polar residue interactions, 1
negatively charged and 1 positively charged residue. The highest number of polar residue
interactions was observed in the analog carfentanyl (aldehyde). This was also the only analog
with 2 positively charged residues present within a distance of 5 Å. The analog ligand with the
most positive docking score, carfentanyl (methyl), also had the lowest number of hydrophobic
interactions. To gain a better understanding of how the ligands interact with the mu-opioid
receptor they direct interactions were analyzed. These interactions include π-π stacking, π-cation,
hydrogen bonding, and salt bridges.
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Table 12. Residues interacting with the analogs within a distance of 5 Å.
Ligand

Salt Bridge

Hydrogen Bond

π-π Stacking

π-Cation

Carfentanyl
(methyl)

-

-

-

-

Carfentanyl
(ethyl)

ASP147

ASP147

TRP293,
TYR326

-

Carfentanyl
(aldehyde)

ASP147

ASP147

HIS297

HIS297

Carfentanyl
(ketone)

ASP147

ASP147

TRP293

-

Carfentanyl
(carboxylic
acid)

ASP147

ASP147

TRP293

-

Carfentanyl*

ASP147

ASP147

TRP293,
TYR326

-

All analogs analyzed had salt bridge and hydrogen bond interactions with ASP147, with
the exception of carfentanyl (methyl). The interactions with ASP147 were observed between the
protonated nitrogen of the cyclohexane of the ligand and the ASP147 residue. Carfentanyl
(methyl) had no direct interactions take place in the binding pocket. This ligand also had the
most positive docking score. Therefore, it can be hypothesized that direct interactions are
essential to better binding. All other ligands displayed π-π stacking interactions, but the
interacting residues varied with each ligand. The two analogs with the most negative binding
energy estimations and some of the most negative docking score were carfentanyl and
carfentanyl (ethyl). Both of these ligands had π-π stacking with TRP293 and TYR326. It can be
hypothesized that π-π stacking is essential to have the strongest binding to the mu-opioid
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receptor. Carfentanyl (aldehyde) was the only ligand that was observed to have a π-cation
interaction, interacting with HIS297. 3D interaction diagrams were then used to better
understand how the position of each ligand in the binding pocket of the receptor influenced the
residue interactions and over docking of the ligand.

Figure 74. 3D diagram of the ligands carfentanyl (methyl) (yellow), carfentanyl (ethyl) (green),
carfentanyl (aldehyde) (cyan), carfentanyl (ketone) (pink), carfentanyl (carboxylic acid)
(orange), and carfentanyl (grey).

The 3D interaction diagram of all the carfentanyl ligands in this group showed the
varying positions of the ligands in the binding pocket of the mu-opioid receptor. Carfentanyl and
carfentanyl (ethyl) were found to have the best docking scores and binding energy estimations,
as well as the same interacting residues. The 3D interaction diagram was used to better compare
the ligands (Figure 75).
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Figure 75. 3D interaction diagram of carfentanyl (grey) and carfentanyl (ethyl) (green).

Carfentanyl and carfentanyl (ethyl) were observed to be in very similar positions in the
binding pocket of the mu-opioid receptor. The most notable difference in their positions was in
the position and orientation of the ethyl group of the carfentanyl (ethyl) and the ester group of
the carfentanyl. The ligands each had the same interacting residues; ASP147, TRP293, and
TYR326 (Figure 76).
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Figure 76. 3D interaction diagram of carfentanyl (grey) and carfentanyl (ethyl) (green) with
interacting residues ASP147, TRP293, and TYR326.

Carfentanyl and carfentanyl (ethyl) displayed a salt bridge and hydrogen bond with the
ASP147 residue and π-π stacking with the TRP293 and TYR326 residues. Based on the 3D
interaction diagram, it can be hypothesized that the distance of these interactions caused by the
differences in positions is what influenced the docking scores and binding energy estimations of
the two ligands. Carfentanyl (ethyl), carfentanyl (ketone), carfentanyl (carboxylic acid), and
carfentanyl all had similar interacting residues (Figure 77).
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Figure 77. 3D interaction diagram of carfentanyl (ethyl) (green), carfentanyl (ketone) (pink),
carfentanyl (carboxylic acid) (orange), and carfentanyl (grey) with interacting residues TRP293
and ASP147.

Carfentanyl (ethyl), carfentanyl (ketone), carfentanyl (carboxylic acid), and carfentanyl
were all observed to have interactions with ASP147 and TRP293. Each ligand interacted with
ASP147 through a salt bridge and hydrogen bond, and with TRP293 through π-π stacking. The
variations in positions of the ligands in the binding pocket can be assumed to be the cause of the
differences observed in the docking scores and binding energy estimations. The carfentanyl
(ethyl) and carfentanyl were also observed to have an additional π-π stacking interaction that
could be responsible for the better binding energy estimations compared to the other ligands.
Carfentanyl (aldehyde) was the only ligand that was observed interacting with the HIS297
residue (Figure 78).
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Figure 78. 3D diagram of carfentanyl (aldehyde) (cyan) and carfentanyl (grey) with the
interacting residues ASP147, TRP293, TYR326 and HIS297. This HIS297 residue is labeled as
HIE297 because the hydrogen is observed on the epsilon nitrogen. The HIE297 residue is only
observed interacting with carfentanyl (aldehyde) through a π-π stacking interaction and a πcation interaction.

The carfentanyl (aldehyde) ligand displayed a salt bridge with ASP147 and a hydrogen
bond with ASP147. Unlike the other ligands, it did not interact with TRP293 and TYR326.
Instead, carfentanyl (aldehyde) was observed to have a π-π stacking interaction and a π-cation
interaction with HIS 297. The 3D interaction diagram displayed carfentanyl (aldehyde) in a very
different position compared to carfentanyl. The position of the benzene ring in the carfentanyl
(aldehyde) was too far from the TRP293 residue to interact but was in closer proximity to the
HIS297 residue leading to that π-π stacking interaction.
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The software ChemDoodle was used to calculate spectral data of the novel analogs
designed in this study. ChemDoodle is able to produce calculated 1H NMR and 13C NMR spectra
of the analogs, as well as determine the mass parent peak. (Figure 79-80)

Figure 79. Spectral data for N-ethyl fentanyl; A) 1H NMR, B) 13C NMR, C) Mass Parent Peak.
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Figure 80. Spectral data for N-propyl fentanyl; A) 1H NMR, B) 13C NMR, C) Mass Parent Peak.

5.4 Conclusions
The objective of this study was to analyze the binding of fentanyl and fentanyl analogs to
the mu-opioid receptor through the use of molecular docking and design and novel fentanyl
analogs to study using the same methods. The first set of analogs examined in this study
involved the parent analogs N-methyl fentanyl and fentanyl along with the novel analogs N-ethyl
fentanyl and N-propyl fentanyl. The rank of docking scores of these analogs was determined to
be N-propyl fentanyl > N-ethyl fentanyl > N-methyl fentanyl > fentanyl. The rank of the binding
affinities was determined to be N-methyl fentanyl > N-ethyl fentanyl > N-propyl fentanyl >
fentanyl. Therefore, it can be assumed that the novel ligands N-ethyl fentanyl and N-propyl
fentanyl will have larger Ki values than fentanyl but smaller than N-methyl fentanyl. The π-π
stacking interactions were determined to be essential to better binding of these analogs to the
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mu-opioid receptor. ASP147 was determined to be the most essential interacting residue for this
group of ligands. Every ligand interacted with ASP147 through a salt bridge and hydrogen
bonding.
The second set of novel analogs analyzed in this study were designed from the parent
analog carfentanyl. The rank of docking scores was determined to be carfentanyl (methyl) >
carfentanyl (carboxylic acid) > carfentanyl (aldehyde) > carfentanyl (ethyl) > carfentanyl
(ketone) > carfentanyl. The most negative binding energy estimation was for the ligand
carfentanyl (ethyl), which was only slightly more negative than the parent analog carfentanyl.
The rank of binding free energy estimations was found to be carfentanyl (carboxylic acid) >
carfentanyl (methyl) > carfentanyl (ketone) > carfentanyl (aldehyde) > carfentanyl > carfentanyl
(ethyl). Therefore, it can be expected that carfentanyl (ethyl) would have a smaller binding
affinity than carfentanyl, correlating to a stronger binding. The other novel analogs are expected
to have a larger binding affinity for the mu-opioid receptor, weaker binding, compared to
carfentanyl. It was determined in this study that the essential residues from strong docking were
ASP147 and TRP293. The position and distance of the ligands from the residues were also
impact the docking of the ligands to the mu-opioid receptor. Additional π-π stacking with
TYR326 was also found to lead to a better docking of the ligands to the receptor, as was
observed in the carfentanyl and carfentanyl (ethyl) ligands. The 3D diagrams used to study the
positions of the ligands in the binding pocket of the receptor displayed varying positions for
some of the ligands with similar core structures. Future work will study what is influencing the
different positions in the binding pocket observed between the ligands.
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CHAPTER 6
THE COMPUTATIONAL STUDY OF KRATOM ALKALOIDS AND THE MU-OPIOID
RECEPTOR

6.1 Introduction
Kratom, or Mitragyna speciosa, is a tree found in Southeast Asia. It is the leaves of this
tree that contain the compounds known for their psychoactive and therapeutic effects. These
compounds are known as kratom alkaloids.58 The leaves of the kratom tree were originally used
in Southeast Asia by workers to keep them awake and alert for long periods of time. Smaller
doses can give effects similar to stimulants, while higher doses produce opioid-like effects.
Kratom has also been used for therapeutic purposes such as aiding in pain, fever, cough,
diarrhea, diabetes and hypertension.59 Popularity of this drug has increased because of its
accessibility. Kratom is sold online, a gas stations and specialty stores and marketed as “not for
human consumption”. It is also believed my some to help with opioid withdrawal, but there have
been no studies to confirm it as a withdrawal aid. A study in 2019 examined the cases of kratom
exposure from 2011-2017 that had been reported to Poison Control Centers. 1807 cases of
kratom exposure were reported from 2011-2017, 11 of which resulted in death. Some of the
reported cases involved only kratom, however a significant number of cases involved kratom and
other drugs leading to the concern of the adverse effects caused by kratom used with other
substances.60
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Of the 1807 cases reported over those six years, two-thirds were seen from 2016-2017.60
The popularity of kratom is increasing, but the DEA still only has it listed as a “Drug of
Concern”. There have been around 44 alkaloids found in the leaves of the kratom plant. Up to 44
alkaloid compounds have been isolated from the leaves of the mitragyna speciosa plant; with
two alkaloids, mitragynine and 7-hydroxymitragynine, being some of the most potent.61 The
potent alkaloids found in leaves are known to interact with the opioid receptors, specifically the
mu-opioid receptor.
The objective of this study was to examine select kratom alkaloids and how they bind to
the mu-opioid receptor through the use of molecular docking. This study will hopefully lead to a
better understanding of how these alkaloids interact with the receptors and shed some light and
if, and how, this substance can be used in positive ways, such as aiding in opioid withdrawal.

6.2 Materials and Methods
Schrödinger’s molecular modeling software, Maestro, was used to examine the binding
of select kratom alkaloids to the mu-opioid receptor. The mu-opioid receptor used in this study
was prepared from the crystal structure, PDB:5C1M, developed by Huang et al.41
6.2.1 Ligand Selection and Preparation
In this study, seven prominent kratom alkaloids were chosen to be analyzed. The
alkaloids used in this study were mitragynine, 7-hydroxymitragynine, speciogynine,
speciociliantine, corynantheidine, paynantheine, and mitragynine pseudindoxyl.
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Mitragynine

7-Hydroxymitragynine

Speciociliantine

Corynantheidine

Speciogynine

Paynantheine

Mitragynine Pseudoindoxyl

Figure 81. Structures of the kratom alkaloids.

The LigPrep protocol is used to successfully convert ligands into three-dimensional
structures. The preparation of the ligands involves generating possible states at a target pH of 7.0
+/- 2.0 using Epik. Epik is used predict pKa values and determine all chemically sensible
structures.18,42

137

6.2.2 Protein Preparation
The Protein Preparation application is used to covert the imported PDB file of 5C1M to
a prepared model ready for docking.54 In order to prepare the mu-opioid receptor the following
steps were taken. Once the PDB file “5C1M” was imported, the modified residue within the
sequence was changed to its proper residue. This information was found within the Protein Data
Bank. The modified residue present in 5C1M was YCM which was changed to the correct
residue, cysteine (CYS). In the workspace the B chain and all the groups present, except 4VO,
were deleted. For preprocess all original hydrogens were removed, waters beyond 5 Å from het
groups were deleted and het states were generated using Epik with a pH of 7.0 +/– 2.0. To refine
the protein, the first step was optimization of H-bond assignment, which was done with sampling
water orientations, using crystal symmetry and minimizing hydrogens of altered species.
PROPKA was used at a pH of 7.0. Waters with less than 2 hydrogen bonds to non-waters were
then removed. Minimization was performed converging heavy atoms to a distance of 0.30 Å with
hydrogens only using the force field OPLS3.
6.2.3 Receptor Grid Generation
The Receptor Grid Generation application is used to accurately place a grid around the
binding pocket of the receptor. The structure present in the mu-opioid receptor model to generate
the grid was 4VO. For this receptor there were no constraints but a rotatable group, TYR 148
was selected for grid generation. The force field used was OPLS3. The grid created was used to
accurately dock the ligands of interest to the receptor.
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6.2.4 Ligand Docking
After the grid was generated and the desired ligands were prepared, the next step was
Glide Ligand Docking. This step allowed for the prepared ligands to be docked into the receptor
binding pocket selected during grid generation. Docking was completed using the standard
precision (SP) method and force field OPLS3. Flexible ligand sampling was selected and Epik
state penalties were added to the docking score. No constraints were selected to use in docking.
The Gide program is able to produce potential ligand conformations. The program uses a set of
ranked filters to find possible locations on the ligand in the binding pocket of the receptor. The
filters include; 1) side-point search, 2a) diameter test, 2b) subset test, 2c) greedy score, 2d)
refinement, 3) grid minimization, and 4) final scoring.43 The Glide Ligand Docking process is
explained by Friesner et al. (2004).43 For each ligand, up to five possible poses were generated
and post-docking minimization was performed. The pose refers to the position and orientation of
the ligand in relation to the receptor.43 To determine the most accurate pose for each ligand, the
docking scores and Glide Emodel scores were analyzed. Docking scores are an estimation of the
binding free energy and are used to rank poses of different ligands. 43,44 The Glide Emodel was
used to compare poses and determine the best, or most likely, pose for each ligand. Docking
scores and Glide Emodel scores are negative. A more negative score means better docking. The
docking of each ligand, when using the same procedure, produces the same values. The
algorithm used by Glide does not require docking multiple times and will produce the same
values each time as long as the same procedure is used. The use of three decimal places is
because differences in some of the values between ligands might not have been seen until the
second or third decimal place. The software allows for more decimal places to be used, but it was
decided to use three decimal places due to some of the small changes observed in the data.
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6.2.5 Binding Energy Estimations: Prime MM-GBSA
The relative binding free energy of each ligand was the estimated using the Prime MMGSBA application. These calculations are done following the equation: MM-GBSA ΔGbind =
E_complex (minimized) – (E_ligand (minimized) – E_receptor (minimized)).22 The solvation
model used was VSGB and calculations were done using OPLS3. Protein flexibility was applied
at a distance of 5 Å from the ligand. The Prime MM-GBSA data values are not the expected to
be the same as the experimental binding affinities but are expected to give a ranking of the
ligands that correlates with the experimental data of binding affinities (Ki values). A more
negative binding free energy value correlates to a stronger binding of the ligand to the receptor. 47
6.3 Results and Discussion
In this study seven alkaloids found in the kratom leaf were analyzed through molecular
docking. The alkaloids were virtually docked to the 3D model of the mu-opioid receptor. The
mu-opioid receptor used in this study came from the crystal structure developed by Huang et al.
Once the ligands were docked their docking scores were analyzed. The docking scores are
estimation of the binding free energy and was used to rank poses of different ligands. 43,44 The
lower, or more negative, the docking score is the stronger the binding is to the CB1 receptor.
When docked, each ligand produced up to five possible poses. To determine the best pose of
each ligand, the Glide Emodel value was used. The lowest, or most negative, value indicates the
best pose for that ligand. Binding energy calculations were then done to determine the relative
binding energy of the best pose of each ligand.
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Table 13. Results from the docking of the alkaloids to the mu-opioid receptor.
Ligand

Ki (nM)(62)

Mitragynine

233 + 48

Docking
Score
(kcal/mol)
–7.109

7-OH-mitragynine

47 + 18

–4.743

–36.071

–34.995

Speciogynine

728 + 61

–7.126

–61.706

–48.202

Speciociliantine

560 + 168

–5.565

–46.101

–36.603

Corynantheidine

-

–6.398

–55.495

–56.288

410 + 152

–5.405

–44.660

–54.237

-

–6.375

–51.821

–53.665

Paynantheine
Mitragynine Pseudoindoxyl

Glide
Emodel
–61.645

Binding
energy
(kcal/mol)
–48.003

*Ki was determined from inhibition of the activity of reference agonist U-50,488.62

The experimental Ki values used for comparison in this study were determined through
radioligand binding assays by Kruegel et al.62 The IC50 values were determined from the
inhibition of the agonist U-50,488. The IC50 value expresses the concentration of the ligand
required to inhibit half of the biological response. The IC50 values were then used to determine
the Ki values using the Cheng and Prusoff equation; Ki = IC 50/(1+[C*]/KD*) 62 The alkaloid
speciogynine was found to have the most negative docking score and 7-hydroxymitragynine had
the most positive docking score. The rank of docking scores was determined to be 7hydroxymitragynine > paynantheine >speciociliantine > mitragynine pseudoindoxyl >
corynantheindine > mitragynine > speciogynine. Binding energy estimations were also
completed within the Maestro software. These values are not expected to be the same as the
experimental binding affinities but are expected to give a ranking of the ligands similar to the
experimental data. A more negative binding free energy value correlates to a stronger binding of
141

the ligand to the receptor. From this data it was determined that the rank of binding energy
estimations is 7-hydroxymitragynine > speciociliantine > mitragynine > speciogynine >
mitragynine pseudoindoxyl > paynantheine > corynantheindine. The estimated binding free
energies calculated in this study were not consistent with the experimental binding affinities.
Kratom, and its alkaloids, has been noted as an emerging drug on the market and research on this
drug is still being done. For that reason, there was very little experimental binding affinity data to
be found on kratom and its alkaloids in the current literature. It can be expected that as more
information becomes available of these alkaloids more computational studies will need to be
performed to better understand their interactions with the opioid receptors.
Using the 2D Ligand Interaction Diagram application in Maestro, the residues interacting
within a distance of 5 Å from the ligand were examined. (Table 14) The types of interacting
residues present within the binding pocket were labeled as hydrophobic, polar, negatively
charged or positively charged residues.
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Table 14. Number and identification of interacting residues within 5 Å for the kratom alkaloids.
Ligand

Docking
Binding Hydrophobic
Score
Energy
(kcal/mol) (kcal/mol)

Polar

Negative
Charged

Positive
Charged

Mitragynine

–7.109

–48.003

20

8

1

2

7-OH-mitragynine

–4.743

–34.995

17

7

1

2

Speciogynine

–7.126

–48.202

20

8

1

2

Speciociliantine

–5.565

–36.603

19

6

1

1

Corynantheidine

–6.398

–56.288

19

6

1

2

Paynantheine

–5.405

–54.237

23

7

1

-

Mitragynine
Pseudoindoxyl

–6.375

–53.665

22

7

1

2

It was observed that speciogynine and mitragynine, with the most negative docking
scores, had the same number of interacting residues. Each ligand had 20 hydrophobic, 8 polar, 1
negative and 2 positive residues. Speciogynine and mitragynine also had the highest number of
polar residue interactions of all the alkaloids. 7-hydroxymitragynine was found to have the most
positive docking score. It also had the lowest number of hydrophobic interacting residues present
within 5 Å. Paynantheine, with a docking score only slightly more negative than 7hydroxymitragynine, had the most hydrophobic residues (23). However, it was the only alkaloid
that did not have any positively charged interacting residues within 5 Å. The positively charged
residues were observed when the distance was increased to 6 Å. Speciociliantine had a docking
score that was slight more negative than paynantheine. This alkaloid was the only ligand with 1
positively charged residue. Corynantheidine and speciocilantine had the same number of
interacting residues except for the additional positively charged residue interacting with
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corynantheidine. After examining the number of interacting residues present within the binding
pocket, it was necessary to analyze the direct interacting residues between the alkaloids and the
mu-opioid receptor. These interactions can include π-π stacking, π-cation, hydrogen bonding and
salt bridge interactions. (Table 15)

Table 15. Residues interacting with the kratom alkaloids within a distance of 5 Å.
π-cation

Hydrogen Bond

Mitragynine

π-π
Stacking
-

-

ASP147

Salt
Bridge
-

7-OH-mitragynine

-

HIS54

-

-

Speciogynine

-

-

ASP147

-

Speciociliantine

-

-

ASP147

-

Corynantheidine

-

HIS54

ASP147

-

Paynantheine

HIS54

-

ASP147

ASP147

Mitragynine
Pseudoindoxyl

-

HIS54

HIS54

-

Ligand

Only two residues were seen to have direct interactions with the kratom alkaloids. These
residues were HIS54 and ASP147. π-π stacking was only observed with one alkaloid,
paynantheine, and the residue HIS54. Paynantheine had one of the more positive docking scores,
but one of the more negative binding energy estimations. π-cation interactions were observed
between three of the alkaloids and the HIS54 residue. The π-cation interactions were observed
between the protonated nitrogen on the cyclohexane ring and the HIS54 residue. The three
alkaloids were 7-hydroxymitragynine, corynantheidine, and mitragynine pseudoindoxyl.
Hydrogen bonding was observed with all but one of the ligands, 7-hydroxymitragynine. 7144

Hydroxymitragynine was also the ligand with the most positive docking score and most positive
binding energy estimation. It can be assumed that hydrogen bonding between alkaloids and the
mu-opioid receptor is essential for stronger binding. Mitragynine pseudoindoxyl was the only
alkaloid that had hydrogen bonding with HIS54, while the remaining alkaloids interacted with
ASP147 through hydrogen bonding. The hydrogen bond between HIS54 and the mitragynine
pseudoindoxy ligand was observed between the -NH group of the cyclopentanone and he
residue. The paynantheine alkaloid was the only alkaloid observed to have a salt bridge
interaction. This salt bridge interaction was with the ASP147 residue. The salt bridge was
observed between the protonated nitrogen of the cyclohexane and the ASP147 residue. Based on
this data is can be hypothesized that the HIS54 and ASP147 residues are essential to the binding
of alkaloids to the mu-opioid receptor.

6.4 Conclusions
The objective of this study was to examine select kratom alkaloids and how they bind to
the mu-opioid receptor through the use of molecular docking. The rank of docking scores was
determined to be 7-hydroxymitragynine > paynantheine >speciociliantine > mitragynine
pseudoindoxyl > corynantheindine > mitragynine > speciogynine. Binding energy estimations
were also completed within the Maestro software. From this data it was determined that the rank
of binding energy estimations was determined to be 7-hydroxymitragynine > speciociliantine >
mitragynine > speciogynine > mitragynine pseudoindoxyl > paynantheine > corynantheindine.
The estimated binding free energies calculated in this study were not consistent with the
experimental binding affinities. Very little experimental binding affinity data is available for
kratom and its alkaloids in the literature. As more data becomes available, the binding free
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energies of these alkaloids will need to be examined further. Essential residues were determined
to be HIS54 and ASP147. Hydrogen bonding was also found to be a crucial interaction for better
docking of the alkaloids to the receptor.
Future studies of the kratom alkaloids through the use of molecular docking will include
the docking of the kratom alkaloids to the other opioid receptors. Some of the kratom alkaloids
have a higher affinity for the delta or kappa-opioid receptor and it will be essential to study the
docking of the alkaloids to each receptor. Other kratom alkaloids, besides the seven mentioned in
this study, will also need to be examined to get a bigger picture of how the kratom alkaloids
interact with the opioid receptors.
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CHAPTER 7
CONCLUSIONS AND FUTURE WORK

The objective of this dissertation was to use a computational approach to predict and
understand new psychoactive substances (NPS). In chapter 2, known and novel synthetic
cannabinoids from the JWH family and how structural characteristics can influence docking and
residue interactions between the synthetic cannabinoids and the CB1 receptor were examined. In
this study the length of the alkyl chain on the naphthalene group of each ligand was analyzed.
The ligands in this study were examined in two phases, each phase consisting of two groups of
ligands. This was done to better understand the influence certain structural characteristics have
on the binding of the ligand to the CB1 receptor and what specific residues interactions are
taking place. It was determined that two structural characteristics were influential on the docking
of the ligands to the CB1 receptor, the carbonyl group between the naphthalene and the indole
and the length of the N-linked alkyl chain. 3D interaction diagrams were utilized to better
understand the influence of the structural characteristics on the position of the ligand in the
binding pocket of the CB1 receptor. Through the 3D interaction diagrams, it was determined that
the presence of a carbonyl group greatly impacts the positions of the ligands. When there was not
a carbonyl present (MGCS-175-073 and JWH-175), the ligands were found to be in very similar
in their positions. The length of alkyl chain on the naphthalene was determined to influence the
position of the alkyl chain; however, it did not appear to influence the overall position of the
ligand in the CB1 receptor.
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In chapter 3, known and novel halogenated derivatives of the synthetic cannabinoids
JWH-018 were studied. This study confirmed the rank of potency determined by Vigolo et al.,
JWH-018 > JWH-018 Cl > JWH-018 Br through the docking scores of these structures. The
novel halogenated derivatives of JWH-018, JWH-018 F and JWH-018 I, were also examined in
this study. The rank of potency when compare to JWH-018 and its known halogenated
derivatives was determined to be JWH-018 > JWH-018 I > JWH-018 Cl > JWH-018 Br > JWH
018 F, based on docking scores. Based on the binding energy estimations, it can be hypothesized
that JWH-018 F would have a smaller Ki value than JWH-018 but a larger, or weaker binding
affinity, compared to the other halogenated derivatives. JWH-018 I can be hypothesized to have
the lowest, strongest binding, Ki value compared to all other ligands in this study. Through 3D
interaction diagrams it was observed that the position of JWH-018 inside the binding pocket of
the CB1 receptor differed greatly from its halogenated derivations which can explain the
differences in interacting residues and the differences in docking scores and binding energy
estimations. JWH-018 F and JWH-018 Cl where observed to be in similar positions in the
binding pocket, which correlates to the similarities seen in their interacting residues. JWH-018
Br and JWH-018 I were observed in opposite positions, compared to JWH-018 F and JWH-018
C, which is correlated to the differences in residue interactions.
In chapter 4, the influence of alkyl chain length of known and novel homologs of the CP
synthetic cannabinoids, CP-47,497, CP-55,244 and CP-55,490 was studied. Three known
homologs of CP-47,497 exist; (C6), (C8) and (C9). In this study each of the synthetic
cannabinoids were examined with (C6), (C8) and (C9) alkyl chains. The docking scores in this
studied showed that each of the (C8) homologs had the best, most negative, docking score in
each group. For the CP-47,497 group, the rank of docking scores was found to be (C9) > (C6) >
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(C7)* > (C8). Based on rank of docking score, the results of this study support those found in the
study by Melvin et al.50 The rank of docking scores for CP-55,244 was determined to be (C7)* >
(C6) > (C9) > (C8) and for CP-55,490 the rank was (C6) > (C9) > (C7)* > (C8). Based on the
data it was hypothesized that the binding affinity values of each of the homologs will be ranked
as the following; for CP-47,497: (C9) > (C8) > (C7)* > (C6) , for CP-55,244: (C9) > (C7)* >
(C8) > (C6) and for CP-55,490: (C8) > (C6) > (C7)* > (C9). Interacting residues were examined
and it was determined that π-π stacking interactions and hydrogen bond interactions are essential
to better docking of the ligands to the CB1 receptor. The position of each of the (C8) homologs
allowed for additional hydrogen bonding that was not observed in the parent ligand. It can be
concluded that the hydrogen bonding is also essential to better docking and binding of the CP
ligands to the CB1 receptor.
The objective of chapter 5 was to analyze the binding of fentanyl and fentanyl analogs to
the mu-opioid receptor and design and novel fentanyl analogs to study using the same methods.
The rank of docking scores of these analogs was determined to be N-propyl fentanyl > N-ethyl
fentanyl > N-methyl fentanyl > fentanyl. The rank of the binding affinities was determined to be
N-methyl fentanyl > N-ethyl fentanyl > N-propyl fentanyl > fentanyl. Therefore, it can be
assumed that the novel ligands N-ethyl fentanyl and N-propyl fentanyl will have larger Ki values
than fentanyl but smaller than N-methyl fentanyl. The π-π stacking interactions were determined
to be essential for better binding of these analogs to the mu-opioid receptor. ASP147 was
determined to be the most essential interacting residue for this group of ligands. The second set
of novel analogs analyzed in this study were designed from the parent analog carfentanyl. The
rank of docking scores was determined to be carfentanyl (methyl) > carfentanyl (carboxylic acid)
> carfentanyl (aldehyde) > carfentanyl (ethyl) > carfentanyl (ketone) > carfentanyl. The rank of
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binding free energy estimations was found to be carfentanyl (carboxylic acid) > carfentanyl
(methyl) > carfentanyl (ketone) > carfentanyl (aldehyde) > carfentanyl > carfentanyl (ethyl).
Therefore, it can be expected that carfentanyl (ethyl) would have a smaller binding affinity than
carfentanyl, correlating to a stronger binding. The other novel analogs are expected to have a
larger binding affinity for the mu-opioid receptor, weaker binding, compared to carfentanyl. It
was determined in this study that the essential residues from strong docking were ASP147 and
TRP293. The position and distance of the ligands from the residues were also impact the docking
of the ligands to the mu-opioid receptor. Additional π-π stacking with TYR326 was also found to
lead to a better docking of the ligands to the receptor, as it was observed in the carfentanyl and
carfentanyl (ethyl) ligands.
In chapter 6 select kratom alkaloids and how they bind to the mu-opioid receptor were
studied through the use of molecular docking . The rank of docking scores was determined to be
7-hydroxymitragynine > paynantheine > speciociliantine > mitragynine pseudoindoxyl >
corynantheindine > mitragynine > speciogynine. From this data it was determined that the rank
of binding energy estimations is be 7-hydroxymitragynine > speciociliantine > mitragynine >
speciogynine > mitragynine pseudoindoxyl > paynantheine > corynantheindine. The estimated
binding free energies calculated in this study were not consistent with the experimental binding
affinities. Interacting residues between the alkaloids and the mu-opioid receptor were also
examined. Essential interacting residues HIS54 and ASP147 were observed for each of the
alkaloids. Hydrogen bonding was observed with all but one of the ligands, 7hydroxymitragynine. Hydrogen bonding was determined to be essential for stronger docking to
the mu-opioid receptor.
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New psychoactive substances (NPS) pose many issues within the criminal justice field.
One of the main issues is the in ability of agencies, like the Drug Enforcement Administration
(DEA), to keep up with the increasing number of NPS that appear on the streets, used
recreationally, and have a high potential of abuse. When a new compound appears, it can take
analysts a significant amount of time to identify the compound and understand its properties. The
work in this dissertation is the foundation of a larger project. The success of this larger project
would lead to a database, that will be made available to all state and federal crime laboratories,
containing potential NPS that could aid in the rapid identification and pharmacological
understanding of new compounds. Rapid identification is essential in the ability of agencies to
schedule the compounds as drugs of abuse and help remove them from the drug market.
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